Generic drugs play an important role in helping to address rising health care costs and in promoting access to medicines. Development and availability of generic drugs is a challenge in the United States and globally. In addition, the requirements and scientific approaches to developing and assessing generic drugs can vary from country to country. To help address all of these issues, FDA established a multi-country forum, the Generic Drug Cluster, to achieve a common understanding of each member agency’s generic drug regulatory requirements and to help increase scientific alignment.

Moderator:
- Mathew Cherian PhD Consultant Self employed - The United States

Participants:
- Sarah Ibrahim, Associate Director CDER, US FDA - The United States

Sleep is a basic human need and it is essential for optimal health and well-being. However, lifestyle and environmental factors are increasingly causing sleep disturbances or sleep disorders. The negative effects of sleep deprivation include physical effects (e.g., sleepiness and fatigue), decline in cognitive function (e.g., diminishment of mental concentration and performance, increasing the risk of accidents and injuries), and mental health complications (e.g., increasing feelings of irritability, anxiety, sadness, and anger, and difficulty to manage stress). Sleep deprivation also increases the risk of chronic diseases. Pharmacists can play a role in managing and supporting people in dealing with sleep disorders through pharmacological and non-pharmacological approaches .

Moderator:
- Jaime Acosta-Gómez, Community pharmacist Farmacia Acosta - Spain

Panellist:
- Erna Sif Arnardóttir, Associate Professor Reykjavik University - Iceland
- Bingqian Zhu, Research Associate Professor, Associate Dean for Research Shanghai Jiao Tong University School of Nursing - China
- Zaswiza Mohamad Noor, Associate Professor, Academic
Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak - Malaysia
- Julie Ann Dopheide,Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences - United States of America

This digital event will describe how professional and regulatory organizations are supporting the pharmacy technician workforce throughout the world. Presenters will also discuss recent initiatives of the FIP Pharmacy Technicians Advisory Committee.

Learning Objectives:
● Identify ways that professional and regulatory bodies support the pharmacy technician workforce
● Recognize the role of advocacy in supporting the pharmacy technician workforce
● Describe recent projects of the Pharmacy Technicians Advisory Committee

Moderator:
- Catherine Schuster, Coordinator of Pharmacy Technician Programs Accreditation Canadian Council of Accreditation of Pharmacy Programs - Canada

Panellist:
- Dana Lyons, Technical Practice Manager Alberta Health Services - Canada
- Abigail Tan, Senior Pharmacy Technician KK Women's and Children's Hospital - Singapore
- Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board - United States

 How digital health is changing care delivery for pharmacists and improving public health

FIPWiSE (Women in Science and Education) is a programme that was launched by the International Pharmaceutical Federation (FIP) on 11 February 2020 on the United Nations’ International Day of Women and Girls in Science. Three years since its launch, several initiatives and transformation tools were introduced including FIPWiSE Toolkit for Positive Practice Environments for Women in Science and Education, FIPWiSE Rising Stars List, Women Leadership Lab, Fearless Podcast Series and Mentorship Programme

This special event is hosted so that, together, we can celebrate the 3^rd year anniversary of FIPWiSE. We will be revisiting the key outcomes delivered, reflecting on their successes, impacts and lessons, and discussing a future for FIPWiSE with the widest reach and social value. We want to reflect how FIPWiSE supports women to in pharmacy achieve their fullest potential, and to attract female students and young professionals into these fields. 

Learning objectives:

1. Celebrate the United Nations’ International Day of Women and Girls in Science.
2. Understand the aim and scope of the FIPWiSE programme and its key initiatives.
3. Discuss how the initiative can further support women in pharmaceutical science and education into the future.

Participants: 
- Catherine Duggan, FIP CEO, The Netherland
- Claire Thompson, FIPWiSE Chair, CEO Agility Life Sciences, UK
- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, FIP, The Netherlands
- Zuzana Kusynova, FIP Lead for Policy, Practice and Compliance, FIP, The Netherlands
- Aysu Selcuk, FIP Educational and Primary Health Care Policies Specialist, FIP - The Netherlands
- Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, FIP, The Netherlands
- Alison Etukakpan, FIP Educational Partnership Specialist, FIPt, The Netherlands
- Lilian Azzopardi, Head, Department of Pharmacy University of Malta, Malta
- Charlotte Rossing, Director of Research and Development, The Danish College of Pharmacy Practice, Denmark
- Marilyn Morris, Distinguished Professor and Chair of the Department of Pharmaceutical Sciences University at Buffalo, US
- Dalal Hammoudi Halat, Common Year Coordinator - QU Health, Qatar University, Qatar

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework permits, a broad range of point-of-care (POC) tests can be performed at community pharmacies or clinical biology laboratories. POC tests can provide valuable information to support health-related decision making and reduce unnecessary presentations to general practitioners or emergency departments. POC tests may also be provided as part of a disease state management service to monitor the outcomes of treatment in people with chronic non-communicable diseases. In addition, pharmacy professionals can use POC tests to intervene and provide safe and quick pharmaceutical care in acute situations.

Attendees will learn about:

1. The role of pharmacy professionals in point-of-care testing;
2. The importance of providing point-of-care testing services in the screening and management of chronic non-communicable diseases and acute situations;
3. Challenges and opportunities for pharmacists in addressing point-of-care testing services.

Moderator:
- Daragh Connolly, Chair of the FIP Board of Pharmaceutical Practice, Ireland

Panellists:
- Sherif Guorgui, President, FIP Community Pharmacy Section, Canada
- Julien Fonsart, Head of the Clinical Biology laboratory, Saint-Louis Lariboisiere University Hospitals, Greater Paris University Hospitals (APHP), France
- Teresa Torres. General Director of GO FAR ANF, Portugal
- Efi Mantzourani, Reader in Pharmacy Practice / Research and Evaluation Lead in Choose Pharmacy, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University / Primary Care, Digital Health and Care Wales, NHS Wales, UK

This webinar will focus on how to develop innovative pharmacy education curricula to better respond to global public health needs. It will also discuss the importance of covering all pharmacy fields and specialties in the pharmacy program, and how to integrate digital health in the global pharmacy education to continuously enhance the quality of education and competencies of the pharmaceutical workforce, as having competent pharmaceutical workforce is critical to providing quality health care services

1. Highlight the importance of quality of education for pharmaceutical workforce to provide high quality health services
2. Understand the innovative pharmacy education curricula
3. Providing effective strategies for comprehensive pharmacy education and training
4. Examining global tools and approaches to integrate e-learning and digital health to enhance the quality of pharmacy education and competencies of health

Moderators:
- Hanane Kebaili, President of the Algerian Early Career Pharmacists Group , Fédération Algérienne de Pharmacie, Algeria
- Abby A. kahaleh, PhD, MS, BPharm, MPH, FAACP, Board of Trustees Faculty & Tenured Faculty of Clinical and Administrative Sciences, RUCSHP, USA

Panellists:
- Abeer Al-Ghananeem, Professor of Pharmaceutics and Biopharmaceutics, Associate Dean for Research College of Pharmacy and Health Sciences, Sullivan University, Louisville, Kentucky, USA
- Anisha Sandhu, FIP AcPS Communication & Collaboration Working Group Member, FIP Technology Forum Committee Member; Assistant Lecturer, Monash University Malaysia School of Pharmacy, Malaysia
- Martin Henman, Associate Professor in the Practice of Pharmacy, The School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland
- Carl Schneider, Associate Professor in Pharmacy Practice, The University of Sydney School of Pharmacy, Faculty of Medicine and Health, Australia

The COVID-19 pandemic highlighted the requirement for current and future pharmacy education to be improved to strengthen the pharmacy profession and improve resilience. With the demand and options at higher education increasing, enrolment strategies have become more critical to pharmacy institutions.

FIP AIM has developed a handbook to support academic pharmacy leaders to update enrolment management strategies in schools of pharmacy. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help global health leaders to implement new enrolment methods.

• Develop strategies to recruit more and better students into pharmacy schools using traditional and social media
• Advocate for the profession, its scope of practice, and its importance in the healthcare system
• Reflect on a global integrated approach to foster student interest and improve admissions

Moderator:
- Pierre Moreau, Dean FIP, Kuwait University, Kuwait

Facilitator:
- Ozge Ozer, FIP Educational Partnership Manager, Turkey

Panellists:
- Lilian Azzopardi, FIP AIM Chair-elect & AIM Advisory Committee member, Head, Department of Pharmacy University of Malta-Malta
- Brian Hemstreet, Associate Dean for Student Affairs University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences-USA
- Frank Moriarty, Pharmacist and senior research fellow RCSI School of Pharmacy and Biomolecular Sciences-Ireland
- Gea Abigail U. Ecoy, Assistant Professor and Chair University of San Carlos-Philippines
- Hanan Refaat, Dean Future University-Egypt
- Marlon Prince, FIP AIM member, Director of Admissions at Howard University College of Pharmacy-USA
- Mohd Zulkefeli Mat Jusoh, FIP AIM member, Dean International Medical University-Malaysia
- Rajani Shakya, Head of Department of Pharmacy Kathmandu University-Nepal
- Wendy Cox,Assoc. Dean, Admissions and Accreditation, University of North Carolina at Chapel Hill Eshelman School of Pharmacy-USA

Telepharmacy has gained increasing importance in the delivery of pharmaceutical care, largely due to the COVID-19 pandemic which has placed enormous pressures on healthcare systems globally. There are some innovative models of telepharmacy services aimed at optimizing and improving access to pharmaceutical care, resulting in improved patient safety and outcomes. However, despite these benefits, major barriers for implementation of telepharmacy remain such as patient confidentiality and privacy of health information.

Attendees will learn about:

1. The global role of telehealth in supporting primary health care services
2. The current trends in telepharmacy around the globe
3. Examples of good practice in telepharmacy

Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden

Panellists:
- Rúben Viegas, Practice Development and Transformation Projects Coordinator, The Netherlands
- Sarah Dineen-Griffin, FIP CPS ExCo member, Australia
- Jaime Acosta, Community pharmacist Farmacia Acosta, Spain
- Josep M. Guiu-Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain
- Derrick Muneene, Unit Head, Digital Health Capacity Building and Collaboration, WHO, Switzerland 

Biorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behavior. An in vitro performance test which mimics the intraluminal performance of an oral dosage form is termed biorelevant. Biorelevant tests have been utilized to decrease the number of in vivo studies required during the drug development process and to mitigate the risk related to in vivo bioequivalence studies.

Prediction of intraluminal performance of an orally administered dosage form and the active pharmaceutical ingredient with biorelevant in vitro performance testing requires appropriate simulation of luminal conditions. Key luminal parameters to be simulated may vary with the process to be simulated, the structure of the active pharmaceutical ingredient and the type of dosage form. A variety of biorelevant media have been proposed, making it now possible to simulate most regions in the gastrointestinal tract in both prandial states. The levels of biorelevance and accompanying decision tree may serve as a useful tool during formulation development, in order to ensure high quality, predictive performance results without unnecessary complexity of media.

• Participants will be introduced in biorelevant dissolution testing
• Participants will be informed on dissolution media that simulates the physicochemical characteristics of the contents of the gastrointestinal lumen
• Participants will be informed on the in vitro methodologies that have been shown to be useful in simulating the intraluminal environment

Chair:
- Horst-Dieter Friedel, FIP Chair Regulatory Sciences and Quality, Director Former at Bayer AG, Germany

Moderator:
- Christos Reppas, Professor in Pharmaceutics National and Kapodistrian University of Athens, Greece

Guests:
- Maria Vertzoni, Associate Professor in Pharmaceutical Technology and Biopharmaceutics National and Kapodistrian University of Athens, Greece

One year after the launch of the FIP global call to action on advancing pharmaceutical education, FIP will report on each region’s progress against the call to action, building on the results of the FIP-UNITWIN inter-regional impact workshops held in November 2022. The event will also host the launch of the FIP Education transformation toolkit, which will be a collection of FIP’s relevant publications and digital events to implement the FIP global call to action on advancing pharmaceutical education.

Objectives:
1. Present progress since 2021 on priority FIP Development Goals of the regions in the context of pharmaceutical education
2. Present progress on FIP-UNITWIN regional roadmaps 2021 and the impact on FIP global call to action on pharmaceutical education
3. Discuss the way forward for the delivery of each regions’ roadmaps with establishment of regional FIP-UNITWIN centres for excellence programme in the months ahead
4. Launch the FIP Education transformation toolkit

Moderators:
- Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences- USA
- Lilian Azzopardi, FIP AIM Chair-elect , University of Malta -Malta

Guests:
- Dominique Jordan, FIP President, Switzerland
- Catherine Duggan, FIP CEO, UK

Panellists:
- Toyin Tofade, President Albany College of Pharmacy and Health Sciences, USA
- Silvana Nair Leite, Professor Federal University of Santa Catarina, Brazil
- Arinola Joda, Assistant Secretary & Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
- Rajani Shakya, Ass.Prof. Department of Pharmacy, Kathmandu University, Nepal
- Mohamad Rahal, Dean School of Pharmacy, Lebanese International University, Lebanon
- Paul Gallagher, Prof.Department of Pharmacy, National University of Singapore, Singapure
- Nilhan Uzman, FIP Lead for Education & Primary Health Policies, Turkey
- Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria

Pharmacists as athlete support personnel have rooted themselves as key players in medical teams serving athletes. Sports pharmacy evolved from a niche practice during the establishment of WADA two decades ago, gaining traction with the publication of the FIP guidelines “The Role of the Pharmacist in the Fight against Doping in Sport” in 2014. Today, we recognise sports pharmacy as a specialty practice, fundamental to the antidoping movement and athlete health. Pharmacists provide accurate sports drug information, avoid inadvertent doping, and coordinate pharmacy services at sporting events. We present two successful models in education and proper training of pharmacists to work with athletes.

Attendees will learn about:

1. Exploring the specialty of sports pharmacy based on expert consensus
2. Discussing a foundation for sports pharmacy curricula
3. Describing a successful example of sports pharmacy practice

Moderator:
- Daragh Connolly, Chair Board of Pharmaceutical Practice, Ireland

Panellists:
- Ashley Anderson, Clinical Sports Pharmacy Specialist / Antidoping Pharmacist International Sports Pharmacists Network, USA
- David Mottram, Emeritus Professor- Liverpool John Moores University, UK
- Mark Stuart, Pharmacist to the International Olympic Committee Medical Commission International Olympic Committee, UK
- Claire May, Academic University of Brighton, UK
- Somer Helvaci, Lecturer IOC accredited sports pharmacist, Turkey
- Shigeo Yamamura, Specially-Appointed Professor Josai International University, Japan

The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.

By the end of the session participants should be able to:
• Understand the roles pharmacists can play in HIV prevention, screening and management
• Recognise some resources and tools that pharmacists can use in this area
• Find and use the FIP toolkit on HIV prevention, screening and management

Moderator:
- Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa

Panellists:
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
- Ali Ahmed, Ph.D. Final Year Student (Clinical Pharmacy) Monash University Malaysia, Malaysia
- Alicia Krüger, Clinical pharmacist Brazilian federal council of pharmacy, Brazil
- Elise HARO-BRUNET, Employed pharmacist CESPHARM (prevention committee) / French Chamber of pharmacists, France
- Romeo Ongpoy Jr, Dean Emilio Aguinaldo College - Cavite Campus, Philippines
- Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, USA
- Hamish Bowden, Senior Clinical Pharmacist (HIV & Sexual Health) The Albion Centre NSW Health, Australia

Long covid, also known as post COVID-19 condition, is estimated to affect 10-20% of people who develop COVID-19. While the majority go on to fully recover, this group of people suffer a variety of physical, physiological and cognitive symptoms for many weeks, months and sometimes longer. The condition can be debilitating and recovery requires a holistic and personalised care approach, including pharmaceutical care.

This event by FIP aims to explore in more depth what long covid is, what the key characteristics and symptoms are and how these symptoms can be managed in the pharmacy. The panellists include a public health expert on long-covid-19, a clinical pharmacist who is recovering from long covid, a physiotherapist and more.

Learning objectives:
1. Describe the key characteristics and symptoms of long COVID-19
2. Understand the latest research and evidence concerning treatment and care
3. Discuss ways long covid symptoms can be managed in the pharmacy
4. Identify the importance of pharmacists' understanding of the condition and care needs

Moderator:
- Leonila Ocampo, FIP Community Pharmacy Section, Asia Pacific Institute for Medication Management Philippine Pharmacists Association, Philippines

Panellists:
- Darren Brown, Clinical Academic Physiotherapist, Chelsea and Westminster Hospital NHS Foundation Trust; Long COVID Physio, United Kingdom
- Rani Khatib, Consultant Cardiology Pharmacist and Associate Professor University of Leeds, United Kingdom
- Lucette Cysique, Associate Professor The University of New South Wales, Australia

Competent pharmaceutical workforce is vital to ensure healthy lives and promote well-being. This is aligned with the FIP Development Goals. Competency-base education (CBE) model became a core of healthcare professions education and training globally.

Some challenges are encountered relating to the implementation of CBE model to initial pharmacy and pharmaceutical education and training (IPET). Hence, FIPEd team has developed the handbook to support pharmacy leaders and educators for their journey of CBE implementation in their education programme. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help them implement CBE.


Learning objectives:
• Understand the importance of CBE in pharmacy and pharmaceutical education
• Describe the structure of FIPEd CBE Implementation Handbook
• Identify how the Handbook can support oneself for their CBE implementation journey

Moderators:
- Marwan Akel, Projects Manager – FIP Workforce development, evidence & impact Journal Editor – Pharmacy Education Journal (PEJ), Lebanon
- Dalia Bajis, FIP Lead for Provision & Partnerships, Bahrain

Panellists:
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK
- Jessica McMullen, Pharmacist and PhD Student University of Nottingham, UK
- Andries Koster, Associate Professor of Pharmacology Dept. Pharmaceutical Sciences, Utrecht University, The Netherlands
- Pierre Moreau, Professor of pharmacology and therapeutics College of pharmacy Kuwait University, Kuwait
- Shaun Gleason, Global Lead for Academic Capacity, FIP Workforce Development Hub, Assistant Dean for Distance Degrees and Programs; Associate Professor of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy, USA

With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to:
• Provide education and development
• Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans.
• Inform the 2023 Commitment to Action and Health Ministers Summit.

Learning objectives:
With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:

1. Outline regional educational and development headline needs in AMR and AMS,
2. Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
3. Input on how they can contribute to the FIP AMR 2023 plans.

Chair:
- Manjiri Gharat, FIP Vice President & Chair of the FIP Commission on AMR, India

Guest:
- Victoria Rutter, Executive Director, CPA, UK

Facilitators:
- Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain
- Chin-Yen Yeo, Senior AMS Pharmacist, Concord Repatriation General Hospital, Australia
- Fiona Doukas, Senior Project Officer, ACSQHC, Australia

Panellists:
- Usman Ebubakar, Senior Lecturer, Universiti Sains Malaysia, Malaysia
- Michelle Gijzelaar, National Clinical Pharmacy Manager, Life Healthcare, South Africa
- Onyeka Chinwuba Obidiegwu, Lecturer, Nnamdi Azikiwe University, Awka, Nigeria
- Roop Gupta, Vice President, IPA, India
- Syamhanin Adnan, Leader, AMS Focus Group for Pharmacist, MPS, Malaysia
- Fitria Nur Hidayah, Clinical Pharmacist, Cipto Mangunkusumo Hospital, Indonesia

With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to:
• Provide education and development
• Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans.
• Inform the 2023 Commitment to Action and Health Ministers Summit.

Learning objectives:
With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:

1. Outline regional educational and development headline needs in AMR and AMS,
2. Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
3. Input on how they can contribute to the FIP AMR 2023 plans.

The US public benefits from reduced costs and improved access to treatment enabled by availability of generics drug products. Patients offer a unique perspective when advocating for accessibility to high-quality and affordable generics. As critical stakeholders, it is important that the FDA Office of Generic Drugs (OGD) captures patient perspectives, needs, and priorities to help better inform patients. This session will explore the role of patients in generic drug development, OGD’s patient engagement sessions to date and the opportunities that can be used to improve patient engagement.

Learning objectives:

• The FDA’s perspectives on patient’s role in drug development
• How Office of Generic Drugs (OGD) is working on patient engagement

Moderator:
- Mathew Cherian, FIP IPS ExCo Member for Webinars, Consultant, USA

Co-moderator :
- Maria Mantziri, FIP IPS ExCo Associate, Pharmacist, Pharmacovigilance Scientist, Greece

Panellist:
- Sarah Ibrahim, Associate Director CDER, Office of Generic Drugs, FDA, USA

As we approach a post-pandemic world, the global supply chain has been greatly influenced by various factors. Many different drug and product shortages have been exacerbated in recent years due to supply chain issues. Through this webinar, we want to give a better overview of understanding the current global supply chain, current threats to the supply chain such as drug shortages, natural disasters, counterfeit medicines, and how to create a resilient supply chain as we move forward in society. We also want to emphasize the value of a pharmacist in this area and the difference they can make.

Learning Objectives:
1. Describe the current global pharmacy supply chain
2. Compare the contrast the different threats to the pharmacy supply chain such as drug shortages, natural disasters, and counterfeit medicines
3. Understand how these threats can interrupt the supply chain from each panel member’s perspective/countries
4. Outline how to create a resilient supply chain and future endeavours taking place to protect the supply chain (i.e., automation and technology)

Moderator:
- Rob Moss, PharmD, Immediate past president, FIP Hospital Pharmacy Section, FIP, European Association of Hospital Pharmacists, The Netherlands

Panellists:
- Yuh Lih Chang, PhD, RPh Director, Department of Pharmacy, Taipei Veterans General Hospital; Principal Investigator, National Drug Shortage management Project; Associate Professor, National Yang-Ming Chiao-Tung University, Taiwan Veterans General Hospital, National Yang-Ming Chiao-Tung University, Taiwan
- Dr. Sohail Fitieh, Ph.D, MS PLA, RPh, Pharmacy & Supply Chain Consultant, United Arab of Emirates
- Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Senior Director, Pharmacy Practice and Quality, American Society for Health-System Pharmacists, USA

The FIP Development Goal 3 (Quality Assurance) Leads have developed a pharmacy education quality assurance tool. It can be used as a self-assessment tool, and for data collection to better understand quality assurance of pharmacy education programmes in different countries around the world.

The questions relate to the pharmacy degrees for initial entry to practice and/or licensure of pharmacists, reflected in three core sections:
1. Accreditation processes and accrediting bodies
2. Standards for quality assurance
3. Views on the value, relevance and outcomes of accreditation in the country

Learning Objectives:
1. To provide the rationale for conducting the FIP Quality Assurance in Pharmacy Education survey
2. To describe the three core sections in the QA tool
3. To provide information on completing the survey and potential benefits

Moderator:
- Abby A. Kahaleh, PhD, MS, BPharm, MPH, FAACP Tenured Faculty & Board of Trustees Faculty Roosevelt University College of Science, Health, & Pharmacy, USA

Panellists:
- Abeer M. AlGhananeem, DG3 Global Lead at FIP Workforce Development Hub, Associate Dean and Professor Sullivan University College of Pharmacy and Health Sciences, USA
- Banan Mukhalalati, Global lead for FIP Development Goal 3: quality assurance Assistant Professor Qatar University, Qatar

The FIP Global Competency Framework for Educators & Trainers in Pharmacy (FIP-GCFE) is a new tool to support advancement and competence development for our colleagues around the world, serving in any sector of pharmaceutical education. It was initiated by the Academic Pharmacy Section of FIP and created in collaboration across FIP, involving our leads, experts, volunteers across the Federation. This works is authored by experienced authors, global leaders in pharmaceutical education who are active in academic, practice and science fields of the pharmacy profession. The commitment to gather their knowledge, experience, values, and efforts, inspiring our colleagues to advance in the field of education, resulted in comprehensive and evidence-based framework.

Participants will be able to:
• Understand how to empower our individual and institutional members, focused on those involved in creating, delivering and assuring quality of pharmaceutical education.
• Learn about the valuable source of information and guide for educators and trainers in pharmacy at individual, organizational, national, and global levels.
• Understand how to use the Framework for their own personal and professional development.
• Start the application, research, and validation of the Framework
• Conduct the self-assessment of competencies according to the Framework

Moderators:
- Astrid Czock, FIP WDH Global Lead; CEO QualiCCare, Switzerland
- Marwan Akel, Projects Manager–Workforce development, evidence & impact Journal Editor – PEJ, Lebanon

Panellists:
- Arijana Mestrovic, FIP AcPS Vice President, FIP WDH Global lead for Competency Development; Director, Professional services
Pharma Expert, Croatia
- Mike Rouse, Director, International Services Accreditation Council for Pharmacy Education. USA
- Martin Charles Henman, FIP AcPS ExCO member Adjunct Assoc. Prof. Trinity College Dublin, Ireland
- Ian Bates, Chair of pharmacy education-University College London, UK
- Catherine Duggan, FIP CEO, Netherlands

This special event is held during a week which marks two significant dates for global health. We will have passed the 1000 days since 30 January 2020 when the World Health Organization declared the COVID-19 outbreak at the time as a Public Health Emergency. The same week will also mark the 4th anniversary since the world, including FIP, came together in Astana in 2018 to endorse the new Declaration of Astana emphasizing the critical role of primary health care. Join us on this special launch event on pandemic preparedness to learn about global pharmacy’s response to COVID-19 and discuss the important of resilient pharmacy and health systems.

Learning objectives:
1. Understand how FIP supported (and continues to support) its members during the pandemic
2. Describe how pharmacy leadership bodies responded to the pandemic across the world
3. Discuss country best practices and lessons for future pandemic preparedness
4. Learn about FIP’s map of primary health care, focusing on strengthening health systems and recovery

Moderator:

- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, Saudi Arabia

Panellists:
- Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA), South Africa
- Hala Sacre, CEO, INSPECT-LB, Lebanon
- Clare Fitzel, Head of Professional Services, Irish Pharmacy Union, Ireland
- Teresa Almeida, Member of the board of directors, Associação Nacional das Farmácias, Portugal
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta
- Leonor Soares, Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal
- Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan
- Atsushi Toyomi, Executive Director, Japan Pharmaceutical Association, Japan
- Sofía Segura, Professor, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica
- Roop Gupta, Chairman, Hospital Pharmacy Division and Vice President, India
- Jack Shen Lim, Treasurer, Malaysian Pharmacists Association, Malaysia
- Daragh Connolly, FIP Chair of BPP,  Ireland

FIP staff:
- Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands
- Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, Saudi Arabia 
- Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan
- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia 
- Nilhan Uzman, FIP lead for education and primary health care policies, The Netherlands

Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.

By the end of the session participants should be able to:
• Understand the importance of flu vaccination, especially for vulnerable population groups, like the elderly
• Recognize the need for improving vaccination coverage rates for both the flu and COVID-19.
• Discuss pharmacists’ contribution to flu vaccination strategies.

Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden

Panelists:
- Joshua A. Mott, Technical Advisor for Influenza and Pandemic Preparedness, WHO, Department of Epidemic and Pandemic Preparedness and Prevention, Switzerland
- Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
- Maria Mendes, Area Manager at the Centre for Medicines Information and Health Interventions (CEDIME) at the National Association of Pharmacies, Portugal National Association of Pharmacies, Portugal

The COVID19 pandemic has highlighted that we need better antiviral therapies, especially for respiratory viral diseases. We have developed inhalation therapies consisting of siRNA nanoparticles which inhibit the viral genome of coronaviruses. The advantage over vaccination is the therapeutic index for virus variants and new coronaviruses. Other so far undruggable targets are transcription factors which are often drivers of tumorigenesis. Accordingly, examples for pulmonary delivery of therapeutic RNA in asthma, targeting GATA-3, and in lung cancer, targeting mutated KRAS, will be discussed.

Learning objectives:
*siRNA nanoparticles for inhalation delivery
*Application to un- druggable targets like transcription factors

Moderator:
Mathew Cherian, ExCo Member, Industrial Pharmacy Section, Consultant-USA

Co-moderator:
Kaushik Desai, Associate ExCo Member, Industrial Pharmacy Section, Secretary General International Pharmaceutical Excipients’ Council of India-India

Panelist:
Olivia Merkel, Professor of Drug Delivery Ludwig Maxmillian University (LMU) Munich, Germany

Inequity has been identified as one of the most serious issues in education worldwide, with multiple causes and consequences. Recent evidence and findings from FIP research indicate that inequities in pharmaceutical education need to be addressed, and this FIP toolkit for addressing inequities in pharmaceutical education intends to motivate, assess, and inform forward thinking changes targeted at transforming pharmaceutical education through addressing inequities globally, across all regions and locally.

At the end of this session, participants will:
1. Learn about the vital inequity themes that impact pharmaceutical education;
2. Understand the importance of having equitable pharmaceutical education;
3. Discuss with the toolkit authors and high-level speakers how to take action towards enabling equitable pharmaceutical education nationally, regionally and globally

Moderator:
- Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA

Guests:
-Catherine Duggan, FIP CEO, The Netherlands

Panelists:
- Nilhan Uzman, FIP Lead for education and primary health care policies, The Netherlands
- Alison Ubong Etukakpan, FIP Educational Partnership Specialist, Nigeria
- Karima Bennara, Chairperson of pharmacy education, International Pharmaceutical Students Federation, Algeria
- Khalid Garba Mohammed, Post doctoral Fellow, Pharmaceutical Engineering Group, School of Pharmacy, Queens University Belfast, UK
- Oliver Grundmann, Clinical Professor The College of Pharmacy, University of Florida, USA
- Neelaveni Padayachee, Senior lecturer and Researcher Department of Pharmacy and Pharmacology, Pharmacy Practice Division, The University of Witwatersrand, South Africa
- Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, Turkey
- Dalal Hammoudi, Associate Dean for Assessment Lebanese International University, School of Pharmacy, Lebanon

Influenza and COVID-19 can have an important impact in health, productivity and quality of life, especially for vulnerable populations. Likewise, both diseases have vaccines that are available and support a lower risk of transmission of the disease.

Pharmacists can play a major role in reminding people to get vaccinated, building vaccine confidence and supporting their decision making, dispensing vaccines and, in some countries, administering those vaccines.  The coadministration of these vaccines can lead to an efficient and convenient way of improving vaccine uptake against both diseases. Community pharmacies’s accessibility and credibility put them in an ideal situation to provide this important service, thus making a valuable contribution to disease prevention.

This digital event will discuss the importance of promoting the coadministration of COVID-19 and flu vaccines as well as strategies for pharmacies’ involvement.

By the end of the session participants should be able to:

• Understand the benefits of vaccine coadministration
• Recognize the need for vaccination coverage in both flu and COVID-19
• Present the FIP Guideline on this topic

Moderator:

- Daragh Connolly, President, Community Pharmacy Section, Ireland

Panellist:

- Mitchel Rothholz, Immunization Consultant, Three-C Consulting, USA
- Lisa Nissen, Professor (Program Director) – Health Workforce Optimisation, Centre for Business and Economics of Health, (Faculty of Business), Australia
- Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal

This will be a 2-part workshop to introduce the FIP YPG Career Development toolkit. Part 1 will review the toolkit, the available resources, and discuss how it will benefit the user. Attendees will then be instructed to work through the toolkit over the next few weeks.

Part 2 of the workshop will be an engaging session where participants are asked to return with their completed toolkits to discuss what they learned with other attendees, review their toolkits in breakout rooms, and have the opportunity to ask questions.

Consumers throughout the world are increasingly looking to the internet to purchase their drugs. The worldwide pandemic has caused many consumers, who had not done so previously, to look to the internet for healthcare, healthcare information and medicinal products. However, at any given time, 95% of the roughly 35,000 online drug sellers worldwide operate illegally, in violation of laws and placing consumers at risk. Drugs purchased through an illegal drug seller on the internet may contain no drug, subtherapeutic levels of a drug, a completely different drug, or toxic chemicals. These websites will appear to be “pharmacies” or other “medical centres” providing credible health care, drug information and safe and approved medications, but are not and present risk to the unknowing consumer.

Regulators throughout the world are monitoring the level of nefarious drug sellers and “medical clinics” on the internet. Regulatory solutions to combat and remove the presence of these harmful vendors and sites have not been widely implemented. Public awareness is an important step, but also raising the awareness among healthcare providers, law makers and social media platforms.

Learning Objectives:
-To identify the level of illegal online drug sellers and bogus medical clinics on the internet and impact on the unsuspecting public
-To identify the barriers to overcome and better protect the public.
To identify programs and initiatives currently in place to combat misinformation, poor virtual care and falsified medication to enhance the safety and protect the internet consumer
-To encourage and support standards for virtual care.

Moderator:
-Ronald Guse, Chair FIP Regulators Forum - Canada
Panelists:
-Mike Isles,Director Alliance for Safe Online Pharmacy-EU-UK
-Justin Macy,Digital Health Senior Manager National Association of Boards of Pharmacy-USA
-Libby Baney,Senior Advisor to ASOP Global; Partner, Faegre Drinker LLP, Alliance for Safe on Pharmacy Global-USA

The demand for travel health and travel medicine services is rapidly growing with the return levels of international travel. Patients are frequently turning to community pharmacies for advice on disease reduction and maintaining personal health whilst travelling. Pretravel preparation is important for many reasons one of which is supporting Global Health policies and strategies.

In some countries legislation has been devolved to allow pharmacists to prescribe medication and vaccinate travellers. However, this is not the situation globally and the many countries place restrictions on this type of pharmacy practice.

Learning objectives:
- To raise the awareness of pretravel consultation service that can be provided in a community setting without prescribing or vaccination.
- To identify over-the-counter products that can be supplied to support travellers visiting a pharmacy
- Compare and contrast classes of over-the-counter products for selected conditions and identify/select appropriate patients for their use.
- Showcase the collaborations with the International Institute of Travel Medicine through membership of ISTM and completion of Certificate of Health

Moderator:
- Daragh Connolly, President Community Pharmacy Section, Ireland

Panelists:
- Derek Evans, Pharmacist Specialist in Travel Medicine Evans Travel Health consultancy, UK
- Karl Hess, Director, Community Pharmacy Practice Innovations Department of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, California, USA
- Sheila Seed, Professor and Chair of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, USA
- Larry Goodyer, Professor of Pharmacy Practice, Leicester School of Pharmacy Faculty of Health and Life Sciences, De Montfort University, UK

The Universal Health Coverage (UHC) Competency Framework was published by WHO as a guide to progress towards building more holistic and integrated health systems. Critically, this includes human resources education and the implementation of Competency-Based Education (CBE) for healthcare workers to ensure adequate, and integrated, education and training.

WHO Universal Health Coverage Competency Framework: https://www.who.int/publications/i/item/9789240034686

Learning Objectives:

1. Overview of the principles and objectives of the WHO universal health coverage competency framework
2. Understand competency-based education and its role in developing the global healthcare workforce for UHC
3. Contextualize the UHC competency development guide to fulfil training needs - based on country of practice
4. Focus on pharmacy and pharmacy support workforce role in UHC

Moderator:
- Abigail Tan Ming Li, Staff training and the planning of continuing education topics. KK Women's and Children's Hospital, Singapore

Panelists:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, United Kingdom
- Siobhan Fitzpatrick, WHO technical officer WHO, Switzerland

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

The Pharmacy Education Journal (PEJ) continues to publish peer-reviewed manuscripts in the general scope of practise domain of pharmacy education (at all stages) and workforce development research and evaluation. PEJ is planning for widening scope by introducing educationally-related short, rapid response articles targeting non-traditional authors (non-academics) in Practice and Science sectors. PEJ is a key global dissemination route.

Event outcomes:

1 Showcase what did PEJ achieve during 20 years, how it was done and present the new plans.
2 Highlight the importance of publishing in the pharmaceutical workforce and education field.
3 Explain the steps from submission to publication: what happens behind the screen and who does it and provide some tips for authors.

Moderators:
- Marwan Akel, Projects Manager – Workforce development, evidence & impact Journal Editor – PEJ, FIP, Lebanon
- Sherly Meilianti, FIP Data and Intelligence Specialist, FIP, Indonesia

Panelists:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, UK
- Lilian M. Azzopardi, Prof. of Pharmacy Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta President, European Association of Faculties of Pharmacy, Malta
- Judilynn L. Niedo-Solidum, Prof. at University of the Philippines Manila College of Pharmacy, Philippines
- Rudi Hendra, Associate professor Indonesian Pharmacists Association, Indonesia
- Shane Desselle, RPh, PhD, FAPhA Professor of Social and Behavioral Pharmacy Touro University California College of Pharmacy, USA
- Jennifer Marriott, Adjunct Associate Professor, Australia

In order to ensure pharmacists maintain currency and quality in their practice, mandatory continuing professional development (CPD) programmes have been implemented by regulatory authorities as part of the licence renewal requirements for continuing practice. This webinar will provide information on the countries having a mandatory CPD programme, the various types of programmes, the regulations and the overall value and monitoring. In addition, information will be provided on CPD for specialized areas of practice, as part of returning to practice and some new concepts to insure currency and quality.

The attendees will learn:
-the overall importance of a mandated CPD programme from a quality assurance and patient safety perspective ;
-the variations of CPD programmes currently in place in various countries;
-the legislation/regulations in place mandating a CPD programme to maintain currency and enhance competence, quality assurance and patient safety;  
-recertification programs for "specialization" and "return to practice"; and,
-other innovative way to insure quality and currency of pharmacists.

Moderator:
- Brett Simmonds, Chair Pharmacy Board of Australia, Australia

Panelists:
- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, France
- Michael Pead, Chief Executive Pharmacy Council of New Zealand, New Zealand
- Trish Farrelly, Manager Registration and Competence Assurance, Pharmacy Council of New Zealand, New Zealand
- Joe R. Anderson, Assistant Dean for Curricular Affairs and Associate Professor of Pharmacy Practice and Administrative Sciences, The University of New Mexico College of Pharmacy, USA

The FIP Hospital Pharmacy Section (HPS) has set out to develop its strategy for the next 5 years. In early 2022, the FIP HPS developed a survey to identify how the FIP HPS can assist FIP Vision/Mission and FIP Development Goals. This survey was sent to FIP Hospital Pharmacy Executive Committee members, Chairs of Committees/Observers, Past Executive Committee members, Hospital Pharmacy Member organisations and regional forums. Results of the survey will be presented with a discussion on the FIP HPS strategy.

Learning objectives:
- To know the results of the FIP HPS strategy survey
- To identify priorities areas for the FIP HPS over the next 5 years
- To participate in the future direction of the FIP HPS

Chair:
-Jonathan Penm, Secretary, FIP Hospital Pharmacy Section, Senior Lecturer The University of Sydney- Australia

Panelist:
-Robert Moss, President, FIP Hospital Pharmacy Section- the Netherlands

With the COVID-19 pandemic, effective use of educational technologies has become essential. Many different aspects of technology have been introduced or further expanded, including remote experiential learning or simulations for virtual patient care. At the same time, artificial intelligence enabled faculties to accelerate and advance research and clinical care in the pharmaceutical sciences and clinical pharmacy practice.

Introduction and implementation of any technology-enabled education and training includes many success factors such as technology literacy amongst educators and students. To enhance technology-enabled pharmaceutical education, this digital event will outline good practices and engage participants in identifying a SWOT (Strengths, Weaknesses, Opportunities, and Threats) of technology and AI use in education.

At the end of this session, participants will: 
1.Learn about current and future good practices about the educational technologies used in higher/pharmaceutical education
2.Contribute to the development of a SWOT in using Technology & AI in pharmaceutical education
3.Identify ways to enhance quality of education and academic capacity by utilizing technology and AI in pharmaceutical education

Co-chairs:
- Lilian Azzopardi, Dean Department of Pharmacy, University of Malta, Malta
- Jaime Acosta Gómez, FIP Community Pharmacy Section, FIP Technology Forum co-chair, FIP COVID19 Expert Advisory Group member; Community Pharmacist and pharmacy owner Farmacia Acosta, Spain

Panelists:
-Mia Sivén, Vice-Dean University of Helsinki, Finland
-Francesca Wirth, Senior Lecturer University of Malta, Malta
-Daniel Malone, Pharmacy Course Director Monash University, Australia

Facilitator:
-Aysu Selcuk, FIP AIM Advisory Committee Member, FIP Education and Primary Health Care Policies Specialist, Turkey

This event will discuss the role of community pharmacists in promoting oral health and the links between oral health and other non-communicable diseases. Also, the event will address the needs for additional training, interprofessional education and collaborative practice models between dentistry and pharmacy. Key interventions by community pharmacists in oral health care from different parts of the world will be presented.

Aim: To discuss the role of pharmacists in oral health, describe how pharmacists’ interventions in oral health can contribute to the prevention of non-communicable diseases, and explore interprofessional education and collaborative practice models between dentistry and pharmacy.

Learning objectives:
1. Understand the importance of oral health in the prevention of non-communicable diseases (NCD), such as cardiovascular and respiratory diseases, cancer and diabetes;
2. Explore the role of community pharmacists in promoting oral health care;
3. Discuss the need for oral health care training and education resources that support pharmacists deliver improved and responsive oral health care interventions;
4. Explore interprofessional collaborative practice models between dentists and pharmacists.

This webinar will announce a new partnership between FIP and Curriculo Solutions to introduce our members to the newly FIP Seal-awarded programme: “Pharmacists for the Future Programme” (PFP).

Curriculo is a UK based training company specialising in leadership and management skills development and career management. They work across various sectors including corporate, health care, education and sport.

The PFP focuses on the development of personal, social and professional skills and provides a strong foundation in the development of key leadership capabilities. The programme aligns with Development Goal 9: Continuing professional development strategies and addresses a skill gap that has been identified by members in leadership development.

During the event, FIP and Curriculo will:

• announce the new partnership for the FIP-sealed PFP.
• describe aspects of the provision and partnerships programme at FIP.
• describe the PFP and hear from previous participants in the programme through the sharing of testimonials.
• describe how FIP members can benefit from this programme.

Early feasibility clinical study was performed to assess the feasibility and tolerability of syringe pump-driven, constant rate (20µl/s), 1-20cP, 5 and 10ml subcutaneous placebo injections to the thigh (5ml only) and abdomen in 32 healthy adults. Endpoints include injection feasibility, depot location, pressure, subject pain tolerability/acceptability and the corresponding tissue effects.

Session Outline:

• Demonstrate the feasibility and broad acceptability of subcutaneous injections up to 10ml and 20cP administered without a permeation enhancer

• Determine if injection site tissue effects are visible and transient as well as the impact of injection site, volume and viscosity on these patterns

• Explore the relationship between subjects’ pain/acceptability and the injection site, volume and/or viscosity

Moderator

- Mathew Cherian, Consultant, Executive Committee Member (IPS), USA

Panellist 

- Wendy D Woodley, Staff Scientist II, Translational & Clinical Sciences, BD Technologies and Innovation, USA

The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.

Learning objectives:

1. To identify the current role of the pharmacist in tetanus, diphtheria, acellular pertussis booster, COVID vaccination, and meningococcal meningitis vaccination.
2. To explore needs, drivers, and barriers for expanding that role in countries that have regulated pharmacy-based vaccination services.
3. To give examples from countries with pharmacy-based vaccination services  in advocating a broader role for pharmacists in vaccination

Moderators:

- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education, University College London, United Kingdom

- Manjiri Gharat, FIP Vice-President, India 

Panellists:

- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, French Chamber of Pharmacists, France

- Zhi Shan Sujata, Pharmacist, Malaysian Pharmacists Society, Malaysia

-  Sham Moodley, Pharmacist,  Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc, South Africa

- Zeid Kilani, President, Jordan Pharmacists Association, Jordan

- Mas Rahman Roestan, Operational Director of PT Biofarma and Expert Council of Indonesian Pharmacists Association, Indonesian Pharmacists Association, Indonesia

- Irma Beatriz Caponi, Farmacéutica, COFA, Argentina

Facilitators & Speakers:

- Christopher John, FIP Lead for Data and Intelligence, UK 

- Zheng Kang Lum, PhD candidate, National University of Singapore, Singapore

- Allie Jo Shipman, Director, State Policy, National Alliance of State Pharmacy Associations, USA

- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia

Over the past 2 decades, virtual education evolved as a new pedagogy within education. Following the experience from the unexpected drastic shift to remote learning and virtual education as a result of the COVID-19 pandemic, educators are faced with dilemmas of how to strike a balance between face-to-face modalities and the virtual platform. Remote learning and virtual education provide opportunities and leadership to develop hybrid models of teaching is now being considered. The webinar will seek to expose experiences and share examples of such opportunities and how to lead faculty towards incorporating the virtual education while ensuring quality education.

The participants who join the webinar will;
• Address assessment of quality of virtual education at the schools of pharmacy
• Reflect on the extent of remote learning after COVID-19 in pharmacy education
• Discuss approaches towards the development of hybrid education in pharmacy schools

Chairs:
-Pierre Moreau, FIP AIM Chair, Dean Kuwait University, Kuwait
-Lilian Azzopardi, FIP AIM Advisory Committee Member, Dean Department of Pharmacy, University of Malta, Malta
-Hanan Refaat, FIP AIM Advisory Committee member, Dean Future University in Egypt, Egypt

Panelists:
-Seif El Hadidi, FIP AIM member, Lecturer in Clinical Pharmacy, Future University in Egypt, Egypt
-Brian Hemstreet, FIP AIM working group member, Associate Dean for Student Affairs and Professor University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
- Jennifer Pham, Clinical Associate Professor, Clinical Pharmacist – Neonatal / Pediatrics, University of Illinois at Chicago College of Pharmacy, USA
- Alan Lau, Professor and Director, International Clinical Pharmacy Education University of Illinois at Chicago College of Pharmacy, USA

Facilitator:
-Ozge Ozer, Educational Partnership Manager, Turkey

Epilepsy is a disorder that afflicts approximately 50 million people worldwide and the WHO has declared epilepsy as a public health imperative. Medications are the mainstay of treating epilepsy, so pharmacist have great role to play in improving the care of people with epilepsy. This Webinar will explore the findings of the recent WHO report on epilepsy, describe ways that pharmacists can be involved in caring for patients with epilepsy, consider advances in new medications, and discuss the challenges of access to medications for many people worldwide.

Learning Objectives:
1. Identify the main barriers to appropriate care of patients with epilepsy as described in the 2019 WHO report on epilepsy.
2. Describe ways that pharmacists can improve the care of patients with epilepsy.
3. Incorporate new antiseizure medications into treatment regimens for epilepsy.
4. Take steps to improve patient access to good quality seizure medications.

Moderator:
-Filipa Alves da Costa, ExCo member of the FIP Social and Administrative Pharmacy Section, Portugal

Panelists:
-Timothy Welty PharmD, College of Pharmacy and Health Sciences Drake University Des Moines, Iowa, USA
-McKenzie Grinalds, PharmD School of Pharmacy Cedarville University Cedarville, Ohio, USA
-Thanarat Suansanae PharmD, School of Pharmacy, Mahidol University Bangkok, Thailand
-Melody Ryan, Professor, University of Kentucky, USA

Approximately 90 percent of prescriptions in the US are generics that often are the product of an intricate global supply chain. The Office of Generic Drugs (OGD) is involved in efforts to advance the international harmonization of scientific, technical and regulatory standards for generic drug development. OGD continues global efforts with a focus on prioritizing future topics for generic harmonization that will include more complex generic drugs. The envisioned outcome of these global efforts is reduced time and cost of product development, consequently improving patient access to more affordable medicines. OGD Global Affairs identifies opportunities and challenges as those national regulations are being developed and implemented positioning regulators proactively on the path of convergence.

Learning Objectives:
1) FDA’s views on global harmonization of regulatory process for generic drugs
2) Identifying opportunities and challenges in arriving at harmonized processes globally.

Moderators:
-Dr Mathew Cherian, Executive Committee Member, Industrial Pharmacy Section, Consultant, USA
-Mr Desai Kaushik , Associate ExCo Member, Industrial Pharmacy Section (FIP), Secretary General, International Pharmaceutical Excipient Council of India, India

Panelist:
-Sarah Ibrahim, Director CDER, FDA, USA

Ongoing learning and professional development are key to components of every occupation. This is especially true for pharmacy technicians working in a constantly-evolving practice landscape. This session will address professional development and advanced training for pharmacy technicians across the world.

Learning Objectives:
● Recognize strategies for continuous learning and professional development
● Identify professional development opportunities designed for pharmacy technicians
● Describe advanced training progams for pharmacy technicians

Moderators: 

- Ryan Burke, Director of Professional Affairs, Pharmacy Technician Certification Board, United States

Panelists:

- Nichole Foster, Program Director, Pharmacy Technician Training Program, Vanderbilt Medical Center, United States

- Peter Karegwa Mwangi, National Chairman, Kenya National Union of Pharmaceutical Technologists, Kenya

- Katherine Watkinson, Branch Liaison Executive, Association of Pharmacy Technicians, UK

Self-care is an integral part of healthcare systems, contributing to healthcare cost savings, better allocation of resources and improved health outcomes in the population. Pharmacists are well placed in the community to support health-related decisions and facilitate informed self-care. FIP aims to support pharmacists in this role through advocacy and by developing professional resources in the area of self-care. This event will showcase a variety of FIP publications, including the launch of a new handbook.

Learning Objectives:
Understand the contribution of self-care to universal health coverage (UHC)
Explore the role of pharmacists in supporting informed self-care
Showcase FIP’s materials in the area of self-care

Moderator:
-Sarah Dineen-Griffin, FIP CPS ExCo member - Australia

Panelists:
-Lars-Åke Söderlund, Vice-President, FIP Sweden
-Daragh Connolly, President Community Pharmacy Section, FIP Ireland
-Christopher John, FIP Lead for Data and Intelligence, FIP UK
-Rúben Viegas, FIP Practice Development Projects Coordinator, FIP Spain

The CPS Champion for Change 2021, Dr Odhiambo David, will share his vision on how pharmacists can better serve patients with mental health issues:
- Describe what service pharmacies should offer patients and/or healthcare systems to help tackle the mental health burden;
- In what ways can pharmacists support self-care and mental health patients having a more autonomous life; and
- How can digital health tools (either low or high tech) help community pharmacists improve outcomes and better support patients with mental health problems

Malaria is responsible for approximately 400 thousand deaths annually, resulting in an enormous public health burden on many of the tropical and subtropical countries. Although projects are ongoing in WHO, pharmaceutical companies and foundations, basic university-based research is also essential against for treatment and drug resistance in malaria. Engagement of young pharmaceutical scientists in the field is necessary to overcome this situation.

In this event, young PI and early carrier scientists / PhD students related to this scientific subject will be invited as speaker. Dr Eizo Takashima, Ehime University, Japan was invited as a speaker for preliminary lecture, and provide opportunity for young scientists to discuss about the science of malaria.

Learning objectives:

• Describe the development of malaria vaccine candidates.
• Defineseroepidemiology of malaria
• Recognize how early carrier pharmaceutical scientists can be involved in research on drug and vaccine development of malaria.

Moderators:
- Takuya Kumamoto, SIG NM Chair, Prof Hiroshima University, Japan
- Rebecka Isaksson, NGPS SIG Chair, Postdoctoral Research Associate UCL Department of Chemistry, UK

Panelists:
- Dr Eizo Takashima,Associate Professor, Ehime University, Japan
- Dr Wei-Chiao Huang, Post-doc State University of New York at Buffalo, US
- Dr Takaya Sakura, Assistant Professor Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan
- Khalid Garba Mohammed, Lecturer, Bayero University, Kano, Nigeria

At this event on World Cancer Day, we will explore innovations in pharmacy practice in the community and hospital pharmacy settings, in terms of supporting cancer patients throughout their journey. A panel of experts will present and discuss examples of innovative professional services in cancer prevention and screening, access to cancer treatments, adherence and continuity across transitions of care, among others.

The goal is to raise awareness of the important role that pharmacists can play in all areas of practice in terms of cancer prevention and management, in collaboration with other healthcare professionals.

Learning Objectives

• Identify and discuss the roles that community and hospital pharmacists can play in cancer prevention and management.
• Present examples of best practices of cancer-related professional services by pharmacists from around the world.
• Discuss the importance of supporting patients in a multi- and inter-professional approach
• Explore issues on the transitions of care, adherence to treatments and prevention and screening in cancer care

Moderators:
• Josep M. Guiu Segura, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain
• Daragh Connolly, President, FIP Community Pharmacy Section, Ireland

Panelists:
• Marko Skelin M.Pharm PhD. Board member of the European Society of Oncology Pharmacy; Assistant Professor, Faculty of Medicine, University of Rijeka, Croatia
• Robert Duncombe, Chief Pharmacist, Director of Pharmacy, The Christie NHS Foundation Trust, Manchester, UK
• Jan de Belie, Professional Affairs Advisor, Pharmaceutical Group of the European Union, Belgium
• Kofi Boamah Mensah, Oncology Pharmacist at Komfo Anokye Teaching Hospital (KATH) and adjunct lecturer at the Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Science, Kwame Nkrumah University of Science and Technology (KNUST), Ghana

Establishing a correlation between in vitro tests and in vivo product performance has always been a challenge for the pharmaceutical industry.  Without a link between specifications and in vivo performance, drug product manufacturing processes are often performed under unnecessarily tight controls. Furthermore, implementing changes post-product market approval can be challenging in a complex global environment.  This webinar will describe traditional and novel approaches towards establishing in vitro in vivo correlations. The main focus will be on solid oral dosage forms, however other dosage forms will also be discussed.

Moderators:
-Andreas Abend, Senior Principal Scientist, MSD, USA
-Horst-Dieter Friedel, FIP Chair Special Interest Group Regulatory Sciences and Quality, Germany

Panelist:
-Patrick Marroum, Senior Director in Clinical Pharmacology and Pharmacometrics AbbVie, USA

Recent technological advancements have revolutionized clinical practice, and there is need for a pharmaceutical workforce that is well-equipped to embrace, innovate, and capitalize on the benefits of digital health. Findings from the 2021 FIP report on digital health in pharmacy education revealed the need to develop courses, training material and experiential learning opportunities to prepare a digitally literate pharmacy workforce.

The Academic Pharmacy Section, supported by the FIP Provision and Partnerships programme, and many FIP constituencies led a ONEFIP project to develop the first FIP-developed online Train the Trainer (TtT) course. At this event, we will reflect on the progress made to date, launch the TtT course, which targets academics as well as educators in any sector in pharmacy, and how this initiative builds on FIP competency frameworks and reports.

Event outcomes:
1. To describe FIP’s response following the release of digital health in pharmacy education report in 2021.
2. To provide an overview of the FIP Global Platform for Provision and Partnerships.
3. To launch the FIP Train the Trainer online course on FIPx and generate interest in the course

Moderators:
- Barry Bleidt, Prof. Nova Southeastern University College of Pharmacy, USA
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK

Panelists:
- Dr. Catherine Duggan, CEO FIP, the Netherlands
- Aukje Mantel-Teeuwisse, Director Utrecht University School of Pharmacy, the Netherlands
- Dr. Dalia Bajis FIP Lead for Provision and Partnerships FIP, Australia/Bahrain
- Nilhan Uzman, Lead for Education Policy and Implementation FIP, The Netherlands
- Jaime Acosta-Gómez, CPS Professional Secretary, Community pharmacist, Farmacia Acosta, Spain
- Prof. Lilian Azzopardi Head, AIM Advisory Committee member, Department of Pharmacy University of Malta, Malta
- Chu-Chen Cheng, Provision and Partnerships Remote Volunteer, Pharmacist FIP, Chaina Taiwan
- Genuine A. Desireh, Provision and Partnerships Remote Volunteer, Pharmacist FIP, Kenya

Medication errors and adverse events cause significant harm to patients’ health and well-being. At this event we will present an overview of the range of Medication Review (MR) services and their definition, highlighting the difference between them and particularly with Medicines Use Review (MUR) in light of recent international updates.

Learning Objectives
• Explore medication review services
• Define MR and MUR
• Present the FIP Toolkit on MR & MUR

Moderator:
Tim Chen, President of FIP Social and Administrative Pharmacy Section, President FIP Social and Administrative Pharmacy Section - Australia

Panelists:
-Filipa Alves da Costa, Assistant professor University of Lisbon, Portugal
-Kurt E. Hersberger, University of Basel, Switzerland
-Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre, Practice Development Projects Assistant (consultancy), Canada

The United Nations General Assembly proclaimed 24 January as International Day of Education, in celebration of the role of education for peace and development. And FIP AIM will be celebrating this special day with a webinar on mental health and wellbeing for academics.

Because the COVID-19 pandemic had led to considerable impact on our physical and mental wellbeing, mental health has become the ‘shadow pandemic’. At this webinar, cultivating mental health and resilience for academics will be highlighted and academic strategies for will be discussed to emphasize the benefits of improved mental health and wellbeing in achieving a better work-life integration.

The participants who join the webinar will;
1. Discover the importance of fostering academic resilience for mental health and wellbeing during unprecedented times and beyond,
2. Address the necessary reasons to raise mental health awareness among academics for students and workplace,
3. Identify institutional strategies in supporting mental health and wellbeing of academic staff and students,
4. Optimize mental health for academic performance in higher education.

Chairs:
-Pierre Moreau, Dean FIP, Kuwait University, Kuwait
-Toyin Tofade, Dean Howard University College of Pharmacy, USA
-Mohamad Rahal, Dean Lebanese International University, Lebanon

Panelists;
-Neil MacKinnon, Provost and Executive Vice President for Academic Affairs Augusta University, USA
-Betty Exintaris, Senior Lecturer, Monash University, Australia
-Fatos Ilkay Alp Yıldırım, Associate professor Istanbul University, School of Pharmacy, Turkey

Facilitators:
-Nilhan Uzman, FIP Lead for education policy and implementation FIP, The Netherlands
-Ozge Ozer, FIP Educational Partnership Coordinator, Turkey

The year 2020 saw the COVID-19 outbreak become a global pandemic which, even by 700 days at the end of 2021, has highlighted how much the world has had to change and we have had to adapt our lives, ways of working, ways of living.

Despite the impact of the pandemic on 2020 business plans and working environments, FIP persevered to deliver and launch the FIP Development Goals for our members and the profession worldwide, understanding the need to provide directions and goals in the coming years as we live with and (hopefully) move out of the pandemic.

In 2021, we ran a full programme to identify the priority goals for the decade ahead across our regions and members. In this event we recap the key outcomes and priorities across the world region which we captured in a new report.

Join us for launch the FIP Development Goals Report 2021 “Setting goals for the decade ahead” which provides a global status update on the goals one year on since their launch and serves as an anchor point that will facilitate the next decade’s roadmap aligned with the UN Agenda 2030.

We will also be launching a new ‘microsite’, a digital platform that serves as a web-based resource for the Development Goals. The microsite collates FIP’s work, publications, events and other outputs mapped to the goals by theme, alongside tools and resources for our members.

Join us in one of FIP’s first events of 2022, where we stand by our commitment now and in the future to support our members to transform pharmacy with clear action, in solidarity with all!

In October-2021, FIP-UNITWIN Regional Workshops brought FIP’s member academic institutions, professional organisations, key pharmacy stakeholders and guests across all regions together to co-create a roadmap to advance pharmacy and pharmaceutical sciences in their region through educational partnerships. At the FIP-UNITWIN Global Summit on pharmaceutical education, participants will.

Learning objectives:
1. Learn about their regions’ roadmap on advancing pharmacy and pharmaceutical sciences education;
2. Explore FIP’s global call to action on pharmaceutical education to support it across their regions and countries;
3. Discover country cases and next steps of the FIP-UNITWIN Centres for Excellence programme

Chairs:

• Catherine Duggan, FIP CEO
• Ralph J. Altiere, FIPEd Chair

Speakers:

• Dominique Jordan, FIP President
• Luis Lorenco, FIP Professional Secretary
• Giovanni Pauletti, FIP Scientific Secretary
• Pierre Moreau, FIP AIM Chair

Panellists:

• Anne Anderson Vice Chair, UK National Commission for UNESCO
• Toyin Tofade, President-Elect of the FIP Academic Pharmacy Section (AcPS) & FIP AIM Advisory Committee Member
• Silvana Nair Leite, FIP AIM Advisory Committee member
• Lilian Azzopardi, AIM Advisory Committee member
• Aukje Mantel-Teeuwisse,FIP Digital Health in Pharmacy Education Report Chair, FIP Technology Forum Member, FIP APS Executive Committee Member
• Beom-Jin Lee, AIM Advisory Committee member
• Rajani Shakya, AIM Advisory Committee member
• Mohamad Rahal, AIM Advisory Committee member
• Rula Darwish, Academic Pharmacy Section Exco
• Paul J. Gallagher, AIM Advisory Committee member
• Mwila Chiluba, AIM Advisory Committee member
• Yahya Choonara, AIM Advisory Committee member
• Arinola Joda, Asst. Secretary/Editor in Chief, APF

Facilitators:

• Nilhan Uzman, FIP Lead for education policy and implementation
• Ozge Ozer, FIP Educational Partnership Coordinator
• Alison Ubong Etukakpan, FIP Educational Partnership Coordinator

Traditionally, the distribution of medicines to consumers has been organized through heavily regulated networks of physical pharmacies. The strict regulation of market structure has been in place to ensure the safety, accessibility and affordability of medicines, but it has also limited competition in the pharmacy sector. Nowadays, the regulation of pharmacies differs between countries, and this has created different market conditions for online pharmacies to operate.

In some countries the online sales of medicines have grown considerably during the recent years as consumers have become more accustomed to e-commerce. More lately the Covid-19 pandemic has dramatically shaped the e-commerce landscape. Due to the pandemic, the demand for online services of pharmacies has increased significantly in many countries. It is also likely that this has changed preferences for some consumers permanently and demand should therefore remain at a higher level in the future.

Increased cooperation between countries in developing regulation of online pharmacies is needed, according to the report, “Online pharmacy operations and distribution of medicines”, which will be published by the International Pharmaceutical Federation (FIP) on December 8th, 2021.

Moderator:

• Lars-Åke Söderlund, FIP Vice President, Executive Advisor, Apoteket AB, Sweden, Sweden

Co-Moderator:

• Sarah Dineen-Griffin, Lecturer, Health Service Management, Charles Stuart University, Australia

Panellist:

• Catherine Duggan, FIP CEO, The Netherlands
• Manjiri Gharat, Principal, K. M. Kundnani Pharmacy Polytechnic, India
  
• Sari Westermarck, Community pharmacist, Finland
  
• Jacqueline Surugue, Immediate Past Vice President FIP, France
• Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE) 
• Jorge Schlottke, Pharmacist, Centro Oncológico Integral de la Provincia de San Luis, Argentina
• John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
• Prosper Hiag, President, African Pharmaceutical Forum, Cameroon
• Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Antimicrobial resistance (AMR) is a major public health threat, which currently kills around 700,000 people each year worldwide. The fight against AMR has been a priority for FIP for many years as it causes a profound impact on global, regional and national health care and economies. The goal of this webinar is to supplement the other FIP webinars being held in November 2021 discussing AMR regionally around the globe. This webinar specifically targets pharmacists involved in hospital and health-system practice settings and will discuss innovative ways to involve pharmacists in infectious disease through AMR and sepsis management.

Learning objectives:
1. Introduce the antimicrobial stewardship program in hospital pharmacy using clinical decision support system
2. Discuss the role and importance of the pharmacist in the management of sepsis
3. Evaluate the use of software and information technology to support antimicrobial stewardship in the critically ill

Moderator:
Krutika Mediwala Hornback, Clinical Pharmacy Specialist - Infectious Diseases/Antimicrobial Stewardship MUSC Health, USA

Panelists:
-Esteban Zavaleta, Director of Pharmacy, Hospital Clinica Biblica, Costa Rica
-Shu-Wen “Wendy” Lin, Director of Pharmacy, National Taiwan University Cancer Center, Taiwan
-Asad “Sid” Patanwala, Professor and Chair of Clinical Pharmacy University of Sydney | Royal Prince Alfred Hospital, Australia

El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP. 

1) Reconocer la contribución del farmacéutico a las estrategias de vacunación y su relación con los objetivos de desarrollo de la FIP y las prioridades de salud globales.

2) Describir los beneficios, el impacto y las barreras de la inmunización en general y la vacunación en particular, así como experiencias de éxito del farmacéutico como inmunizador a nivel global.

3) Identificar experiencias de éxito del farmacéutico en América Latina en vacunas y su participación en las distintas etapas de la cadena de inmunización-

4) Reconocer las áreas de servicio de la inmunización en el quehacer farmacéutico y las herramientas disponibles para el desarrollo de servicios farmacéuticos de inmunización desde los diferentes ejes de su competencia.

The document "Pharmaceutical services in immunisation: Contributions, experiences and implementation in the Americas region", authored by the Drug Information Centre of the Pharmaceutical Research Institute of the Faculty of Pharmacy of the University of Costa Rica for the Pharmaceutical Forum of the Americas, provides an overview of the involvement of the pharmacy profession in immunisation in Latin America. This introductory webinar will provide an overview of the document’s content and how it relates to the FIP Development Goals. This document is intended to be a tool for the implementation of pharmaceutical services in immunisation in the region, which also complements other reports issued by FIP. The document is available in Spanish, English and Portuguese.

1) Recognise the pharmacist's contribution to immunisation strategies and their relationship to FIP Development Goals and global health priorities.

2) Describe the benefits, impact and barriers of immunisation in general and vaccination in particular, as well as successful experiences of pharmacists as immunisers globally.

3) Identify successful experiences of pharmacists in Latin America in vaccines and their participation in the different stages of the immunisation chain.

4) Recognise the service areas of immunisation in pharmacy and the tools available for the development of pharmaceutical immunisation services from the different areas of their competence.

Cytotoxic drugs compounding is one of the most risky activity among all pharmaceutical operations in a Pharmacy. This has led pharmacists to multiply check points at each critical step and in-process controls to keep that risk at the lowest, as reported in numerous publications. What can technology bring in terms of safety, speed, convenience, and reliability in such complex environments ? Three exemples will be discussed in this webinar: CSTDs, IV workflow management system with IA technology and video recording, and robotic compounding.
And if you are addicted to serious games, come and see how you can increase your competencies while training in immersive virtual reality in a real cytotoxic drugs compounding environment

Moderators:
-Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, Immediate past FIP Vice President and Liaison Officer for the African Region
Hospital Pharmacist, Hospital Practitioner, Centre Hospitalier Georges Renon, Niort, France
-Josep M. Guiu Segura, HPS ExCo, Head of pharmaceutical planning and pharmacotherapy coordination Consortium of Health and Social Care of Catalonia, Spain

Panelists:
-Benoit Le Franc, Pharmacist Pharmacien hospitalier gérant PUI GHLRRA-co-fondateur chez EUREKAM SAS-inventeur Drugcam, France
-Agnés Bobay-Madic, Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
-Mirjam Crul, Pharmacist, Board Member, European Cancer Organisation, Special Network on the impact of COVID-19 on Cancer Co-Chair and workforce Network Co-Chair, The Netherlands
-Shao-Chin Chiang, Pharmacist Sun Yat-Sen Cancer Centre, Taiwan

3D printing offers the potential to revolutionise the production of pharmaceuticals targeted to the gastrointestinal tract by offering a flexible drug product manufacturing platform that can adapt readily to changing market and patient needs.
When will a pharmacist be able to use each patient’s individual information — such as age, race, gender or constitution — to produce their optimal medication dose, rather than relying on a standard set of doses? Could there be a time when a pharmacist will be able to print drugs in a complex construct of layers? When will patients be able to print their medicines at home?

Describe the generalities related to 3D printing of medicines.
Understand the opportunities, issues and regulation related to 3D printing of medicines.
Learn how different technological tools allow personalised 3D printed medicines.
Outline a practical experience in 3D printing in pharmacies

Moderator:
- Jaime Acosta, Community Pharmacy Section’s Executive Committee Member, FIP CPS, Spain

Panellists:
- Alvaro Goyanes Goyanes, Co-founder and Director of Development, FabRx Ltd, United Kingdom
- Patrick van Oirschot, Director | Consultant, GPP Support, Netherlands
- Jan Saevels, Scientific Director, Association of Pharmacists Belgium (APB), Belgium

Building on World Health Professions Alliance (WHPA), Positive Practice Environments Campaign, the “FIPWiSE toolkit for positive practice environments in education & science” is developed to identify and address inequalities in the workplace environments which affects women in pharmaceutical science and pharmacy education, with transferable learnings across the pharmaceutical workforce. The toolkit is designed to raise awareness and provide possible solutions for individuals, employers and institutions that can enable positive practice environments for women in pharmaceutical science and pharmacy education.

Learning objectives:
1. Explore the key factors that enable positive practice environments for women in pharmaceutical science and pharmacy education, and the entire pharmaceutical workforce
2. Learn about practical solutions for professionals, employers and policy makers in creating positive practice environments for women in pharmaceutical science and pharmacy education
3. Discuss with the toolkit authors and high-level speakers how to take action and standi up for positive practice environments

Moderator:
- Claire Thompson, Chair of FIPWiSE - UK
Facilitator:
- Nilhan Uzman, FIP Lead for Education Policy and Implementation - Netherlands

Panellists:
- Dominique Jordan, President FIP,Switzerland
- Catherine Duggan, CEO FIP, FIPWiSE Executive Sponsor,Netherlands
- Dalal Hammoudi, FIP WiSE steering committee member & FIP AMR commission member,Lebanon
- Ecehan Balta, FIPWiSE working group member,Turkey
- Nisa Masyitah, FIPWiSE Remote volunteer,Switzerland
- Alison Etukakpan, FIPWiSE working group member, Educational partnership coordinator FIP,Nigeria
- Aysu Selcuk, FIP Educational Partnerships Coordinator, FIPWiSE project coordinator,Turkey
- Belma Pehlivanović, FIPWiSE Remote volunteer,Bosnia and Herzegovina
- Esther Anyango, FIPWiSE Remote volunteer,Kenya
- Iris Mwanza, WGH Co-chair,USA
- Lina Bader, FIP Lead for EquityRx Program,SA

New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?

Learning objectives:

• Understand the changing landscape of healthcare and pharmacy
• Identify how new actors use technology to transform pharmacy services
• Understand how digital transformation and tools support new business models and services, as well as is shaping a new patient/consumer behaviour
• Describe how FIPs PHC strategy and the DGs can be used to transform pharmacy practice
• Define a strategy for transform pharmacy linked to the "new normal"

Moderator:

• Lars-Åke Söderlund, President the FIP Community Pharmacy Section, Executive Advisor at Apoteket AB, Sweden
• Jacqueline Surugue, FIP Vice President, FIP Technology Forum Chair, Hospital Pharmacist at a 1300 beds hospital, France 

This webinar will present the professional practice in the hospital setting using health digital technologies. Digital Innovation, how to develop digital skills in pharmacy personnel Telepharmacy and mHealth is the content of the first part. It is relevant to discuss “mHealth” because the access to mobile phones is almost universal and the costs of this technology will be able to be addressed by many countries. The objective of the second part will be: “Discuss current use of mHealth by patients and providers and the impact on hospital care in Midwestern United States” "Medication use technology" would complete the webinar.

Learning objectives:
1. Compare the “European” model of digital technologies for hospital pharmacy with the “American” one.
2. Explain the concept of medication error risk mitigation.
3. Get aware with Medication Use Technology employed throughout the medication use process

Moderator:
- Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, France 

Panellists:
- José Manuel Martínez Sesmero, Director of Pharmacy in Hospital Clínico San Carlos (Madrid), Spain
- Katherine A. Miller, Sr. Director – Acute Care Pharmacy and Clinical Nutrition,The University of Kansas Health System, USA
- Dr. Johlee S. Odinet, Johlee S. Odinet Medication Safety Supervisor  Ochsner Medical Center, USA

mRNA technology was used in developing the first ever COVID vaccine, developed by Pfizer / BioNtech. A number of vaccine or therapeutic products are in developing this technology. This webinare will address the following:

• What is mRNA? (structure and chemistry)
• How does it work in a cell (as either a therapeutic or vaccine)?
• How is it made and at what scale?
• How is it analyzed and characterized?
• By what means can it be delivered to the patient?
• What were the biggest challenges to get mRNA vaccines out to the public in 2020?
• What other notable clinical advances have been made for mRNA based medicines?
• What future directions do we see for mRNA as a therapeutic tool?

Moderator:

• Mathew Cherian, ExCo Member, Industrial Pharmacy Section Consultant, USA

Panellists:

• Michael McCaman PhD (U Cal at Davis), Managing Director, BDO USA
• Seth Alexandert PhD (Yale), Associate Director, Resilience, USA

This event will focus on the role that pharmacists can play in providing pharmaceutical care for people with hearing impairment or a disability linked to hearing loss. Pharmacists must provide clear messages and adapt their communication strategies to this particular population group to ensure optimal use of medicines and medical devices, and they need to have the knowledge and skills to do so. Also, people with hearing loss face different challenges and this problem becomes more relevant with age. Pharmacists can support patients in detecting early signs of hearing loss and taking the appropriate actions.

Learning objectives:

• Understand how hearing impairment or deafness impact a patient’s quality of life and their capacity to communicate with healthcare professionals.
• Learn about what pharmacists can do to support patients and carers with these conditions.
• Improve communication strategies to advise patients with hearing impairment on how to achieve an optimal use of medicines and medical devices.

Moderator:

• Tara Hehir, SAPS Secretary, Consultant Pharmacist, Australia

Panellists:

• Kasper Bergmann, Vice President World Federation of the Deaf, Denmark
• Kenneth Bitrus David, MSc Pharmacology and Drug Development Candidate Hull York Medical School, University of Hull, Nigeria/ United Kingdom
• Fiorella Donato Zúñiga, Pharmacist, Coordinator of "Programa Salud Inclusiva" (Inclusive Health Program) Acceso Visual , Costa Rica

Poor medication adherence has emerged as a major public health concern in the last decade, and pharmacists may play a vital role in medication adherence by implementing many of the solutions demonstrated at COVID-19.

FIP adapted the theme "Pharmacy: Always trusted for your health" for World Pharmacy Week; and expanding on that theme, FIP would like to welcome your attendance to this event. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1 to discuss the role of pharmacists in medication adherence and communication.
2 to share some regional and global thoughts on the common communication gaps and challenges that are experienced in all patient facing sectors
3 to highlight various regional and global strengths, accomplishments, and success stories in terms of medication adherence and communication in pharmacy.

FIP Technology Forum brings you the webinar about Virtual reality (VR). VR has been widely studied and applied in numerous medical applications. In pharmacy, VR can potentially be applied in wide range of activities, from drug design and discovery, though pharmacist education, to in-patient counseling and behavior modification. In this webinar we bring you the examples of VR technology applications in pharmacy. In our webinar, we will showcase and immersive virtual reality in a virtual environment with experience from Finland with our speaker Mia Siven from Helsinki University, where the VR was successfully applied in pharmacy education. We will then present a showcase of immersive virtual reality in a real environment, with speakers Agnes Bobay Madic and Paul Besnier with their example from France. VR technology has become increasingly affordable, flexible, and portable, enabling its use for therapeutic purposes in both inpatient and outpatient environments. But despite the compelling features of VR, a number of challenges exist, such as validation of clinical efficacy, cost/accessibility and usability issues, technical capabilities, acceptance, among others. You will have the opportunity to ask questions in the panel discussion part of the webinar.

Moderator:

• Jacqueline Surugue, FIP Vice President, Hospital Pharmacist, France

Panellists:

• Eeva Teräsalmi, Community Pharmacist, Owner Seven Brothers Pharmacy, Helsinki, Finland
• Mia Siven, FIP Technology Forum Chair Vice-Dean, University of Helsinki, Finland
• Agnès Bobay-Madic. Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
• Paul Besnier, Pharmacy Intern, Centre Hospitalier Universitaire de Caen Normandie, France

Counterfeit, substandard and falsified medications and medical products endanger public health and FIP believes that pharmacists and pharmaceutical scientists should contribute to patient safety by actively participating in the fight against counterfeit, substandard, and falsified medicines.
Adapting and expanding on the theme of World Pharmacy Week (Pharmacy: Always trusted for your health), we would like to invite you to attend this webinar and learn more about the role of pharmacists in the emerging threat of counterfeit, falsified, and substandard medicines. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1- to discuss the role of pharmacists in combating counterfeit, falsified, and substandard medicines.
2- to highlight various regional and global strengths, accomplishments, and success stories in the fight against counterfeit medications.
3- to identify emerging regional and global threats and challenges related to counterfeit medication.

Moderator:
- Lars-Åke Söderlund, President Swedish pharmaceutical society - Sweden 

Panellists:
- Catherine Duggan, CEO FIP, The Netherlands
- John Hertig, Vice-Chair and an Associate Professor of Pharmacy Practice, USA
- Manjiri Gharat, Vice-President, Indian Pharmaceutical Association, India
- Stephanie Kohl, Policy & Advocacy Officer, Belgium 
- Sally Galal, Associate Professor, Alexandria University, Egypt
- Dieudonne NZEYIMANA, Pharmacist and Sales Manager, Rwanda
- Renae Beardmore, Acting National President, Australia
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
- Pierre Souverain, Pfizer
- Caitriona Scott, Pfizer
- Gudrun Hubinger, Pfizer
- Zuzana Kusynová, Lead for Policy, Practice and Compliance, FIP, The Netherlands

The Høst-Madsen Medal is the highest pharmaceutical science award of FIP and it is awarded every second years. The award is named after Danish pharmaceutical scientist and former FIP president Dr Erik Høst-Madsen and is made possible with the support of the Association of Danish Pharmacies (Danmarks Apotekerforening). This year we will present the award, during a digital event, to Prof. Hideyoshi Harashima, of Hokkaido University, Japan.

The event will start with short presentations on the nanomedicine/drug delivery theme from three young researchers from different countries, after which Prof. Harashima will provide some commentary. The event will continue with the president of FIP presenting the medal and certificate to Prof. Harashima, after which Prof. Harashima will give a lecture on “Multifunctional envelope-type nano devices: From controlled intracellular trafficking to clinical application for nanomedicines”.

Participants in the event will have the opportunity to send their messages and congratulations to Prof. Harashima via the Q&A box or chatbox in Zoom.

Moderator:
- Ross McKinnon, Chair of Board of Pharmaceutical Sciences, FIP - Australia

Panellists:
- Dominique Jordan, President FIP - The Netherlands
- Hideyoshi Harashima, Professor of Pharmaceutics and chair of Laboratory of Molecular Design of Pharmaceutics, Hokkaido University - Japan
- Dr Schultz, Research Associate, University of South Australia - Australia
- Dr Yamada, Associate Professor, Hakkaido University - Japan

All three domains of pharmacy; science, education, and practice are crucial for pharmacists to solidify and expand their role in various health systems. As early-career pharmacists, we sometimes lack professional direction and well-defined opportunities in our profession. FIP is actively involved in all aspects of pharmacy practice, pharmaceutical science, and education, mostly via the work of member associations and committed volunteers.

The purpose of this webinar is to introduce early career pharmacists and pharmaceutical scientists in Bahrain to the International Pharmaceutical Federation, the Young Pharmacy Group, and the FIP Development Goals.

Join us for an interactive session to discover more about how you, as a Bahraini pharmacist, can stand in solidarity with pharmacists all over the world to advance pharmacy. **The event is also open to pharmacy students.**

Moderators:
-Farah Aqqad, FIP Regional Engagement and Project Coordinator International Pharmaceutical Federation, Jordan
-Sherly Meilianti, FIP Data and Intelligence Specialist, International Pharmaceutical Federation, Indonesia

Facilitator:
-Abrar Husaini, Volunteer Pharmacist Al Shamil Field Hospital, Bahrain

Panellists:
-Lucas Ercolin, FIP YPG Chairperson of Public Relations, PUI Health Project Manager, FIP Young Pharmacists Group (YPG), Première Urgence Internationale (PUI), Brazil
- Ikwaibom Umoiyoho, FIP YPG Chairperson of Projects, Hospital Pharmacist Zenith Medical and Kidney Center, Nigeria
- Dalia Bajis, FIP Lead for Provision and Partnerships, International Pharmaceutical Federation, Bahrain
- Lina Bader, FIP Lead for Workforce Transformation & Development, International Pharmaceutical Federation, Saudi Arabia
- Abrar Husaini, Volunteer Pharmacist, Al Shamil Field Hospital, Bahrain

This event is for hospital and health-system pharmacists and leaders to review best practices for advanced and specialist pharmacist development in the hospital setting. Content will include information about the European Association of Hospital Pharmacists (EAHP) Position Paper on Hospital Pharmacy Specialisation and the FIP Hospital Pharmacy Section Basel Statements in relation to the future of clinical pharmacy practice.

Learning objectives:
a. Have an increased awareness of the competencies required of a hospital pharmacist
b. Understand global initiatives in progression and recognition pathways for advanced practice and specialisation
c. Identify resources available for use of the FIP HPS Basel Statements in the hospital pharmacy advanced practice
d. Identify new competencies that hospital pharmacists will need in the future

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, Saudi Arabia

Panellists:
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP), Hungary (home country), Belgium (country in which EAHP is based in)
- Kirstie Galbraith, Associate Director, Workforce Development Hub, Global Lead, Advanced and Speciality practice (DG4), Workforce Development Hub, Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University - Australia
- Josep Maria Guiu Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia - Spain

For students and early career pharmacists or pharmaceutical scientists, it can be difficult to know where to find support and guidance when considering professional development and career trajectory.

This FIP YPG webinar seeks to introduce young pharmacists and pharmaceutical scientists to both the Young Pharmacists’ Group and the International Pharmaceutical Students’ Federation as professional organizations that can offer many benefits to their members.

The learning outcomes include:
1. Attendees will gain insights about the organizational structure of FIP, YPG, and IPSF.
2. Learn about networking and volunteer opportunities of these organizations.
3. Learn about the benefits of membership in these organizations.
4. Hear first-hand accounts of how membership in these organizations has impacted members.

Chair:
- Louisa Sullivan, Clinical Pharmacist, University of Washington Medical Center - USA

Co-moderator:
- João Guedes, IPSF President 2020 - 2021, International Pharmaceutical Students’ Federation (IPSF) - Portugal

Panellists:
- Renly Lim, Research Fellow, University of South Australia - Australia
- Ikwaibom Umoiyoho, Hospital Pharmacist, Zenith Medical and Kidney Center - Nigeria
- Safiye Çağansel, Pharmacist In Charge, Treasurer & FIP Liaison, Safiye Çağansel Eczanesi, Cyprus Turkish Pharmacists’ Association - Cyprus
- Oussama MADADI, IPSF President-Elect 2020 - 2021, International Pharmaceutical Students’ Federation (IPSF) - Algeria
- Karima BENNARA, Chairperson of Pharmacy Education 20-21, International Pharmaceutical Students’ Federation (IPSF) - Algeria

Participantes:

- Santos Nicolau (Bastonário da Ordem dos Farmacêuticos de Angola);

- Elisabete Jacinto (Membro do Policy Statement Working Group da FIP sobre o papel do farmacêutico nas doenças não transmissíveis);

- Leonel Almeida (Coordenador de Assistência Farmacêutica da Secretaria Municipal de Saúde de Porto Alegre, Brasil);

- Elisabete Barros (Coordenadora do Programa Nacional de Luta contra as Doenças Não Transmissíveis, São Tome e Príncipe).

he choice of delivery device or container closure system versus the Reference Listed Drug is a key consideration when developing a biosimilar. Can a biosimilar be developed using a different container closure system than the reference Listed Drug and if yes, how different can this container
closure system be? If the reference is in a vial or a prefilled syringe, can the biosimilar be in an autoinjector? What are additional requirements that need to be considered in order to be able to claim interchangeability.

Learning objectives:
1. we focus on requirements applicable to biosimilars when targeting the US or the EU markets.
2. we discuss acceptable differences in device-component between a biosimilar and the
reference product.
3. we address a few case studies.

Moderator:
- Mathew Cherian, Consultant - USA

Co - Moderator:
- Kaushik Desai, Advisor , Indian Pharma Machinery Manufacturers Association - India

Panellist:
- Alison Bascou, Senior Regulatory Affairs Manager, Becton- Dickinson - France

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine that can result in waste and harm including avoidable hospital attendances and admissions. Hospital pharmacists can be an important part of the asthma pathway and powerful change agents. This webinar will provide updates on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from experts from the Asthma Right Care social movement about how to make impactful change happen in the provision of asthma care within secondary care settings.

By the end of this webinar participants will have:
1. Received a critical update on international asthma guidelines and the implications for hospital pharmacists
2. Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and acute care and how to use the right medicines in the right way
3. Discussed what leadership opportunities, motivation and capabilities are needed to bring about change such as improved discharge from emergency departments and respiratory wards; and shared approaches between hospital and community pharmacists.

Chair:
- Ema Paulino, Professional Secretary, FIP - Portugal
Panellist:
- Marina García-Pardo, Family physician, IbSalut, Mallorca - Spain
- Toby Capstick, Consultant Pharmacist - Respiratory Pharmacist, Leeds Teaching Hospitals NHS Trust - United Kingdom

This Pharmacy Technician Symposium is the 3rd in a series and focuses on Pharmacy Technician regulations in the context of practice, education, continuing professional development and organizations. Four Pharmacy Technicians will share their experience

Learning objectives:
1. Review recent trends in regulations that enable better patient access to care
2. Provide a quick review of literature on the topic of Pharmacy technician regulation, related to practice, education, continuing professional development and organizations
3. Understand how regulations have impacted a diverse set of global markets
4. Share global case studies of how pharmacy technician regulation positively impacts patient care in practice
5. Identify best practices in regulatory advancement that support the pharmacy technician profession preparing for the decade ahead

Moderator:
- Vijay Sarma, VP–Expert Audience Marketing, McCann Health - Canada
Co-Moderator:
- Abigail Tan Ming Li (KKH), Pharmacy Technician, KK Women's and Children's Emergency Pharmacy - Singapore

Panellists:
- Jennifer Falkenrath, Bureau Manager, Division of Occupational and Professional Licensing in the State of Utah - United States of America
- Cristiano Matos, Pharmacy Technician, Farmácia Coimbra - Portugal
- Sakhumhlanga Goci, Pharmacy Technician, Eastern Cape Department of health, Cecilia Makiwane hospital mdantsane - South Africa
- Peter Karegwa Mwangi, National Chairman, Kenya National Union of Pharmaceutical Technologists - Kenya

Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites.   This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.

The attendee will learn:

1)      The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.

2)      The value of Apology Legislation on medication error resolution, transparency and patient confidence.

3)      The value of centralized medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.

4)      The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.

Moderator:
- Ronald Guse, FIP Regulators Forum Chair, NABP - Canada

Speakers:
- Prof. Aslani Parisa, University of Sydney - Australia
- Jan Byrd, Director, Health Policy Healthcare Excellence - Canada
- Mitul Jadeja, Vigilance and Risk Management of Medicines (VRMM) Division, Medicines and Healthcare products Regulatory Agency, MHRA - UK
- Alison Reid Executive Director, International Association of Medical Regulatory Authorities (IAMRA) - Australia
- Andi Shirtcliffe, Chief Advisor - Pharmacy, Office of the Chief Medical Officer, Ministry of Health - New Zealand

A Direct Application of the FIP Basel Statements on Human Resources, Training and Development & Aligned with FIP Development Goals.

Both the FIP Development Goals and the Hospital Pharmacy Section Basel Statements list the competency of the pharmacy workforce as important. In a listing of priority goals from the DG and the BS, FIP members identify competency goals as a top priority. The HPS Vice Presidents also list competency as a high priority for advancing hospital pharmacy practice. The webinar will address curricula and ongoing continuing education to provide students and practitioners with the necessary knowledge and skills for contemporary hospital pharmacy services.

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences, University of Cincinnati - USA

Panellist:
- Daniel Kibuule, Associate Dean, - Hage Geingob Campus, University of Namibia - Namibia
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd., H-8/4, Islamabad - Pakistan

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine. Community pharmacy can be an important part of the asthma pathway and powerful change agents. This webinar will update on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from community pharmacists in the Asthma Right Care social movement about how to have impactful conversations about personal, national and international change and how to make it happen.


By the end of this webinar participants will have:
-Received a critical update on international asthma guidelines and the implications for pharmacists
-Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and how to use the right medicines in the right way
-Discussed what opportunities, motivation and capabilities are needed to bring about change.

Moderator:
- Ema Paulino, General Manager Ezfy, Portugal

Panellists:
- Francesc Moranta Ribas, Community Pharmacist, Farmacia Sanz Guiilén, Spain
-Darush Attar-Zadeh, Respiratory Lead Pharmacist, Community Pharmacy Locum Independent Prescriber, Cross Chemist North Central London Clinical Commissioning Group, UK
-Debbie Rigby, Director, Pharmeducation Clinical Associate Professor, Queensland University of Technology, Brisbane, Australia

The “FIP UNITWIN Pathfinder Toolkit” is a step-by-step guide to support the global expansion of the FIP-UNESCO UNITWIN programme. It will also support academic institutions across Africa to establish an Africa-wide association of schools of pharmacy, with the leadership of African Pharmaceutical Forum and building on the experiences of similar associations around the world.

At the end of this session, participants will:

1. Learn about the FIP-UNESCO UNITWIN Programme and the value of educational partnerships
2. Share expressions of interest to join new FIP-UNESCO UNITWIN centres for excellence at their regions
3. Discuss the way forward for the establishment of an African-wide association of schools of pharmacy

Moderators:
-Ralph Altiere, Dean and Prof. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
-Prosper Hiag, President African Pharmaceutical Forum,
Cameroon

Panellists:
-Nilhan Uzman, FIP UNITWIN Programme Lead, FIP Lead for Education Policy and Implementation, The Netherlands
- Anne H Anderson, Vice Chair UK National Commission for UNESCO, UK
- Alison Ubong Etukakpan, FIP Educational Partnerships Coordinator, Nigeria
-Wanda Maldonado, Dean & Representative University of Puerto Rico & COIFFA, Puerto Rico, USA
-Cyril Usifoh, Prof. and former Dean University of Benin, Nigeria
- Yahya E. Choonara, Prof. and Head of the Dep. of Pharmacy and Pharmacology, University of the Witwatersrand, South Africa
-Chiluba Mwila, Lecturer & Research University of Zambia, Zambia
-Gisèle Étamé, Head of Department of Pharmaceutical Sciences University of Douala, Cameroon
- Aysu Selcuk, Lecturer Ankara University, Turkey
- Khalid Garba Mohammed, Lecturer Bayero University, Nigeria
-Arinola E. Joda, Head of Clinical Pharmacy and Biopharmacy Department, University of Lagos, Nigeria
-Reda Djidjik, President & Prof. Algerian Federation of Pharmacy, Algeria

Participantes

- Ema Paulino , Membro do Comité Executivo/ Secretária Profissional da FIP

- Eduardo Tavares, Presidente da Entidade Reguladora Independente da Saúde (ERIS)

- Artur Nhanengue, Diretor dos Serviços Farmacêuticos do Hospital Central de Maputo (HCM) Moderador Santos Nicolau, Bastonário da Ordem dos Farmacêuticos de Angola

The FIP Pharmacy Practice Research SIG (PPR SIG) was created with the main scope of increasing pharmacy practice contributions to global health through the provision of greater access to the latest high-quality international pharmacy practice research. The PPR SIG also aims to cultivate an international forum for the dissemination of quality, international pharmacy practice research for all stakeholders and stimulate communication, discussion, networking, and collaboration between international pharmacy practice stakeholders.

Based on this objective, this PPR virtual summer meeting aims to increase the quality and quantity of pharmacy practice research by exchanging and disseminating information at an international level. New networks and collaborations will be established on major themes for experienced researchers and higher degree students. 

This workshop aims at presenting the state-of-art of systematic reviews and meta-analyses in the biomedical field. An overview of the main changes of the new PRISMA statement (2020) compared to the previous version (2009) is provided. Our role as researchers and healthcare professionals in enhancing science reliability is also discussed.

Webinar promovido pela AFPLP - FIP/YPG - APJF com as participações de:

- Catarina Nobre (Associação Portuguesa de Jovens Farmacêuticos)

- Filipa Ferreira (Secção Jovem da Federação Internacional Farmacêutica)

- Jorge Batista (Associação de Farmacêuticos dos Países de Língua Portuguesa)

Dissolution testing is an important physiochemical test for the development of solid oral dosage forms. As a quality control test, the dissolution test is used for assessment of drug product quality and is specified for batch release and regulatory stability studies. In vitro dissolution test results
can often be correlated with the biopharmaceutical behavior of a product. This webinar provides a summary
of views from major global agencies (Europe, Japan, United States), pharmacopoeias, academia, and
industry. Based on available guidance and literature, this webinar summarizes highlights for development
and validation of a suitable dissolution method, setting appropriate specification.
Clarify the importance of dissolution testing within the pharmaceutical lifecycle.
Learning objectives:
• Understand the concept of Dissolution Testing
• Learn which parameters are relevant for the development of a dissolution method
• Learn how to validate the dissolution method
• Learn how to set suitable specifications

Moderator:
Jobst Limberg, Head of Unit Scientific Quality in European Procedures, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) - Germany

Panellist:
Horst-Dieter Friedel, Former Director, Former Bayer AG - Germany

La farmacia humanitaria durante el covid-19. Gestión de desafíos durante una nueva era 

En este webinar discutiremos cómo diversas organizaciones humanitarias -FSF-Argentina, FSF-Chile y FSF-España- centradas en el trabajo de farmacia, se han adaptado a la pandemia de COVID-19.
Objetivos de aprendizaje:
1. Comprender cómo puede continuar el trabajo humanitario en tiempos de pandemia.
2. Conocer varios ejemplos de trabajo humanitario durante la pandemia de COVID-19.
3. Obtener nuevas ideas y construir redes dentro del campo de la farmacia humanitaria.
 
Los temas se basan en el  trabajo, incluyendo desafíos e innovaciones, que tres organizaciones (de España, Argentina y Chile) han desarrollado durante la pandemia de COVID-19

O tema deste evento digital é o papel do farmacêutico no combate e gestão dos Medicamentos Falsificados e Substandards.

Esta pandemia acentuou as inequidades e as dificuldades no acesso aos medicamentos essenciais que promovem ainda mais este flagelo global.

Ouviremos a experiência da implementação do guia curricular da FIP desenvolvido para suporte à capacitação de farmacêuticos no combate a medicamentos falsificados e substandards, seguida da partilha das intervenções desenvolvidas em Angola, Moçambique e Portugal.

Os oradores partilharão a sua visão e experiência, permitindo a participação e debate de participantes dos 7 países de Lingua Portuguesa.

Biopharmaceutical drug product development is a multistage process that involves various activities from molecule design to process engineering and validation. QbD based approaches can help connect consecutive stages of product development to each other and ultimately to the desired clinical performance. The webinar will address practical approaches to utilizing QbD based approaches for biologics drug product formulation and process development as well as manufacturing using case studies as examples.

Learning objectives:
*How QbD is applied to discrete stages in biologics development and manufacturing
*Application of QbD that is phase- appropriate
*Case studies of real- life examples

Moderator:
Mathew Cherian, Consultant - USA
Co-moderator:
Maria Mantziri, Quality Project Manager, IPS ExCo Associate - Germany

Panellist:
Krishnan Sampath, Executive Director, Analytical and Drug Product Sciences MacroGenics - USA

A webinar entitled “Challenges and Opportunities for the Pharmaceutical Profession in the Lusophone Space - Vector-borne diseases” will take place on 28 April at 19:00 CEST, delivered jointly by the International Pharmaceutical Federation (FIP) and the Association of Pharmacists of Portuguese-Speaking Countries (AFPLP) in Portuguese language. This webinar will be based on the FIP Handbook for Pharmacists on vector-borne diseases, produced in collaboration with the Pharmaceutical Forum of the Americas. The speakers will present and discuss case studies from various Portuguese-speaking countries of the unique role of pharmacists in the prevention and management of vector-borne diseases. 

Um webinar intitulado “Desafios e Oportunidades para a Profissão Farmacêutica no espaço lusófono –Doenças transmitidas por vetores” terá lugar no dia 28 de abril, às 18:00 horário de Portugal, organizado conjuntamente pela Federação Internacional Farmacêutica (FIP) e a Associação de Farmacêuticos dos Países de Língua Portuguesa (AFPLP) em língua portuguesa. Este webinar será baseado no Manual da FIP para Farmacêuticos sobre doenças transmitidas por vetores, produzido em colaboração com o o Fórum Farmacêutico das Américas. Os oradores apresentarão e discutirão estudos de caso de vários países lusófonos sobre o papel único dos farmacêuticos na prevenção e gestão de doenças transmitidas por vetores. 

Pharmacy technicians have a critical role in the delivery of healthcare and patient care services. This webinar will offer an overview of current research and publications about pharmacy technicians’ contributions. Speakers will also discuss the importance of data, evidence, and research related to pharmacy technician practice and describe current literature that demonstrates the value of the pharmacy support workforce.

Learning objectives:
· Understand the importance of data, evidence, and research related to the role and practice of pharmacy technicians
· Learn about the many contributions of pharmacy technicians on an international level
· Describe recent and upcoming publications regarding pharmacy technicians

Moderator:
- Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board PTAC - United States
Co-moderator:
Teri-Lynne, Fogarty Lecturer/ Coordinator of Pharmacy technician programme Nelson Mandela University PTAC member - South Africa

Panellists:
- Kimberly McKeirnan, Associate Professor, Pharmacotherapy Director for the Center for Pharmacy Practice Research Washington State University, PTAC Member - United States
- Charlotte Verner Rossing, Director of R&D
Pharmakon, Danish College of Pharmacy Practice, Vice-chair FIP Special Interest Group on Pharmacy Practice Research - Denmark
- Tamara Köhler, Consultant and lecturer, PhD Candidate FPZ-instituut -Netherlands
- Michael Mungoma, Dean, School of Pharmacy Mount Kenya University PTAC Member - Kenya

Generic drugs provide significant public health benefits by providing high-quality, more affordable alternatives to brand name drugs. Approximately 90 percent of prescriptions dispensed in the United States are generic drugs that often are the product of an intricate global supply chain. The Office of Generic Drugs (OGD) is involved in
efforts to advance the international harmonization of scientific, technical and regulatory standards for generic drug development. The outcome of these global efforts is reduced time and cost of product development, consequently improving patient access to more affordable medicines. FDA’s efforts at international harmonization of standards for generic drugs will be reviewed. The financial impact of this harmonization on development costs and consequent easier access for patients to generic drugs will be discussed. The harmonization efforts would help regulatory agencies in the timely approval of generic drugs thereby accelerating access to affordable, safe, effective, and high-quality generic medicines for the American public.

Learning Objectives:
- Financial impact of harmonized international standards on global access to less expensive medications
- FDA’s operational modalities for generic drug approvals
- FDA’s efforts at international harmonization of scientific, technical and regulatory standards

Moderator:
- Mathew Cherian, ExCo Member, Industrial Pharmacy Section, FIP -

Panellists:
- Sarah Ibrahim, Associate Director, FDA, Center for Drug Evaluation and Research (CDER) - USA

What to do next? is a question many young, aspiring pharmaceutical scientists ask themselves as they progress in their education or early on in their careers. This webinar aims to inspire participants that are considering an academic career by showcasing two pharmaceutical researchers who have chosen an academic career. The speakers will reveal what was their motivation and how they navigated to their current position, what from their education was most valuable to their current career, and what experiences they have gained along the way.

Learning objectives:
- Participants will be able to compare an academic career in two different regions.
- Participants will learn what was required for the two speakers to reach their current role and use this to plan their own career.
- Participants will gain insights from the speakers on how to design/fulfill the key steps that make an early career researcher stand out.

Moderators:
- Sifei Han, NHMRC Early Career Fellow, Drug Delivery Disposition & Dynamics, Monash University - Australia
- Sarah Dineen-Griffin, Lecturer, Health Services Management, School of Biomedical Sciences, Charles Sturt University - Australia
- Khalid Garba Mohammed, Department of Pharmaceutics and Pharmaceutical Technology, Bayero University - Nigeria

Panellists:
- Stephanie Reuter Lange, Cancer Council Mid Career Research Fellow, University of South Australia - Australia
- Lirui Wang, Professor, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University - China

What to do next? is a question many young, aspiring pharmaceutical scientists ask themselves as they progress in their education or early on in their careers. This webinar aims to inspire participants that are considering a career in industry by showcasing two pharmaceutical researchers working in the pharmaceutical industry. The speakers will reveal what motivated their career choices, provide their best tips for securing a position in industry, and what opportunities they see in the future.

This event aligns with FIP Development Goals 2 and 9.

Learning Objectives:

- Participants will be able to compare a career in two different pharmaceutical companies.
- Participants will learn what was required for the two speakers to reach their current role and use this to plan their own career.
- Participants will gain insights from the speakers on how to design/fulfil the key steps that make an early career researcher stand out.

Moderators:
- Dr Khalid Garba Mohammed, Department of Pharmaceutics and Pharmaceutical Technology, Bayero University - Nigeria
- Dr Rebecka Isaksson, Postdoctoral Research Associate, Department of Chemistry, University College London - UK

Panellists:
- Dr Tim Foley, DNA-Encoded Library Selection & Primary Pharmacology Lab Head, Pfizer - US
- Ms Shivani Baldeo, Retail Strategy and Innovation Lead African Cluster,
AstraZeneca - South Africa

After the COVID-19 pandemic, current and future pharmacy education needs to be improved to strengthen the pharmacy profession. With the demand for higher education increasing, enrolment strategies are becoming more critical to pharmacy institutions. From attracting and recruiting of students, through career development after graduation, the development of new strategies is required to support the future of pharmacy schools around the world.

Learning Objectives:
- Defining key areas of challenge in pharmacy education regarding prospective students, including attracting, training, developing and leading them
- Contributing to motivation and professional development to ensure career progression for pharmacy graduates
- Careful planning to address short term needs in pharmacy education while ensuring support for the future of pharmacy schools around the world in the long term
- Identifying new ways to develop the pharmacy profession such that it is strengthened and continuously improves

Moderator:
- Carlo Marra , Dean, School of Pharmacy University of Otago - New Zealand

Facilitator:
- Ozge Ozer, FIP Educational Partnership Coordinator, FIP - Turkey

Panellists:
- Dalal Al-Taweel, Vice Dean of Academic and Student Affairs, Faculty of Pharmacy, Kuwait University - Kuwait
- Rosana Isabel dos Santos, Professor, Federal University of Santa Catarina - Brazil
- Toyin Tofade, Dean and Professor, Howard University College of Pharmacy - USA
- Karima Bennara, Chairperson of Pharmacy Education Committee, IPSF - Algeria
- Louisa Sullivan, Clinical Pharmacist, University of Washington Medical Center - USA

This webinar will provide an educational programme to support hospital pharmacists in developing preceptor skills, especially with regards to currently trending areas in pharmacy education. Furthermore, commonly encountered challenges and potential solutions to address them will be presented.

At the end of this webinar, attendees will be able to:

- Utilise skills and strategies to effectively precept students, residents, and interns in the hospital setting
- Incorporate preceptor skills with regards to currently trending areas in pharmacy education
- Address commonly encountered challenges as a preceptor using different potential solutions

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice & Administrative Services, University of Cincinnati - USA

Speakers:
- Phuoc Anne Nguyen, Pharmacy Manager, Houston Methodist West Hospital - USA
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd. - Pakistan
- Matthew Hung, Clinical Staff Pharmacist, St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre - Canada

The ‘’FIP digital health in pharmacy education’’ report describes the readiness, adaptability, and responsiveness of pharmacy education to train current and future pharmaceutical workforce on digital health as well as knowledge and skill gaps of the pharmaceutical workforce to respond to the technological transformation. The launch event will showcase key findings from the ‘’FIP digital health in pharmacy education’’ survey, describe good practices on digital health education initiatives and a panel will be conducted to identify a roadmap for digital health education. Participants will have an opportunity to take part in a live simulation of a digital health education solution!

Learning Objectives:

- Learn about the key findings from the FIP Digital health in pharmacy education survey;
- Explore good practices on course descriptions, examples of assignments and learning activities on digital health,
- Identify areas of development for the long-term vision of digital health in pharmaceutical practice, science and education

Moderator:
- Aukje Mantel-Teeuwisse, Utrecht University School of Pharmacy - The Netherlands

Facilitator&Speakers:
- Nilhan Uzman, FIP - The Netherlands
- Sherly Meilianti, University College London - UK
- Bidhata Khatri, FIP - India

Speakers:
- Jaime Acosta Gomez, Farmacia Acosta - Spain
- Claudia Rijcken, Pharmi - The Netherlands
- Timothy Aungst, Massachusetts College of Pharmacy and Health Sciences - USA
- Lilian Azzopardi, University of Malta - Malta
- Karima Bennara, University of Batna - Algeria
- Whitley Yi, Well Dot Inc - USA
- Sara Ramadan, PharmaVgate Academy - UAE
- Catherine Duggan, FIP - The Netherlands
- Jacqueline Surugue, FIP - France
- Ema Paulino, FIP - Portugal
- Giovanni Pauletti, University of Health Sciences & Pharmacy in St. Louis - USA
- Ralph Altiere, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - USA

This online seminar will give an introduction to the MCS concept for the development of oral solid dosage forms (tablets and capsules). It will give case studies of its application throughout the drug development process in the areas of formulation design, process development, materials science and characterization of both API and drug product. There will be opportunity for discussion around the path forward for the MCS initiative, as well as barriers seen to future implementation.

Delegates will learn the principles of the MCS concept and how to apply it to both batch and continuous manufacture. Examples will be given of how MCS can be combined with modelling to improve drug development.

This event is organised by the Academy of Pharmaceutical Scientists (APS), the FIP Drug Delivery and Manufacturing Special Interest Group and the Board of Pharmaceutical Sciences of FIP.

Moderator:
- Michael Leane, Associate Scientific Director, Bristol Myers Squibb - UK
- Tetsuya Ozeki, Chair for SIG on Drug Delivery and Manufacturing, International Pharmaceutical Federation (FIP) - Japan

Speaker:
- Kendal Pitt, Senior Technical Director, GlaxoSmithKline - UK
- Iris Ziegler, Director Pharmaceutical Sciences & QbD, Corden Pharma International GmbH - Germany
- Gavin Reynolds, Astra Zeneca - UK
- Neil Dawson, Senior Principal Scientist, Pfizer - UK

This session will examine the application of the concepts of the Health Belief Model (HBM) which is one of the first and still most commonly used frameworks or theories of health behavior. There has been successful application of the HBM in health and wellness programs, including immunization and chronic diseases management. As such, the application of HBM will be illustrated in a flu awareness campaign that targeted Lebanese University students. Examples of improving immunization rates and addressing patient perceptions in an ambulatory care setting in the U.S. will also be discussed.

Additionally, this session will discuss the application of the Continuing Professional Development (CPD) model to train pharmacists with the knowledge and skills in emergency preparedness and response, including mass vaccination.

Learning Objectives

1. Examine successful health initiatives using the HBM. (AK)
2. Describe two vaccination campaigns and programs in different populations to address vaccine hesitancy and improve vaccinate rates for flu and COVID-19 vaccines. (NM and SS)
3. Apply the Continuing professional development (CPD) model for pharmacists and student pharmacists to have structured approach for preparing health promotion programs, including COVID-19 mass vaccination.

Moderator:

- Naoko Arakawa, Assistant Professor in International Pharmacy, University of Nottingham - UK

Panellists:

- Abby Kahaleh, Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty, Roosevelt University - USA
- Nisreen Mourad, Clinical Associate Professor, Lebanese International University - Lebanon
- See-Won Seo, Assistant Professor and Clinical Pharmacist, Albany College of Pharmacy and Health Sciences - USA
- Hoai-An Truong, Professor and Director of Public Health, University of Maryland Eastern Shore - USA

Moderator: Rula Darwish

Speakers:Zeid Kilani, Falah Eddy, Ian Bates, Lina Bader, Dalia Bajis, Kirstie Galbraith

Panelists: Shepard Mhalaba, Asmaa Al Hagan, Desak Ernawati, Arit Udoh

The presentation is available here.

The presentation is available here.

FIP’s Hospital Pharmacy Section is organising a webinar on “Good storage and distribution practices for pharmaceutical products in hospitals”.

The correct storage and distribution and the continuous improvement of the processes involved in the supply chain from the acquisition to the administration or use of pharmaceutical products in hospitals, have a direct economic impact and improves quality assurance in patients care.

Learning objectives:

1. Understand variables that affect the stability of pharmaceutical products.

2. Understand storage and distribution processes.

3. Evaluate good storage and distribution practices that improves quality processes.

4. Highlight new technologies that benefit good practices for pharmaceutical products.

Presentation outline:

- Define variables that affect the stability of pharmaceutical products.

- Define storage and distribution processes for pharmaceutical products.

- Provide examples of good practices.

- Present new technologies that benefit good practices of storage and distribution.

Moderator: Nora Gerpe

Speakers: Martín G. Silveira and Javier Movilla

Stress is defined as any type of change that causes physical, emotional or psychological tension, and it has been dubbed as “the health epidemic of the 21st century” by the World Health Organization. Stress is the body's response to any situation that requires attention or action, and everybody experiences some level of stress. However, high levels of stress may lead to various physical, mental, and emotional symptoms such as muscle tension, headaches, fatigue, sleep disorders, irritability, increased heart rate, and difficulty in breathing. Chronic stress is also a risk factor for the development or exacerbations of non-communicable diseases. Pharmacists have an important role in helping people prevent and manage stress though pharmacological and non-pharmacological approaches.

Moderator:
- Filipa Alves da Costa, Assistant Professor Faculty of Pharmacy, University of Lisbon - Portugal

Panellists:
- Carole Spiers, Chair International Stress Management Association - UK
- Hahn, Martina, Clinical pharmacist University hospital Frankfurt and Department of mental health, varisano hospital Frankfurt Hoechst - Germany
- Ricardo Cintra, Clinical Phycologist Farmácia Moreira Barata, Lda - Portugal

Generic drugs play an important role in helping to address rising health care costs and in promoting access to medicines. Development and availability of generic drugs is a challenge in the United States and globally. In addition, the requirements and scientific approaches to developing and assessing generic drugs can vary from country to country. To help address all of these issues, FDA established a multi-country forum, the Generic Drug Cluster, to achieve a common understanding of each member agency’s generic drug regulatory requirements and to help increase scientific alignment.

Moderator:
- Mathew Cherian PhD Consultant Self employed - The United States

Participants:
- Sarah Ibrahim, Associate Director CDER, US FDA - The United States

Sleep is a basic human need and it is essential for optimal health and well-being. However, lifestyle and environmental factors are increasingly causing sleep disturbances or sleep disorders. The negative effects of sleep deprivation include physical effects (e.g., sleepiness and fatigue), decline in cognitive function (e.g., diminishment of mental concentration and performance, increasing the risk of accidents and injuries), and mental health complications (e.g., increasing feelings of irritability, anxiety, sadness, and anger, and difficulty to manage stress). Sleep deprivation also increases the risk of chronic diseases. Pharmacists can play a role in managing and supporting people in dealing with sleep disorders through pharmacological and non-pharmacological approaches .

Moderator:
- Jaime Acosta-Gómez, Community pharmacist Farmacia Acosta - Spain

Panellist:
- Erna Sif Arnardóttir, Associate Professor Reykjavik University - Iceland
- Bingqian Zhu, Research Associate Professor, Associate Dean for Research Shanghai Jiao Tong University School of Nursing - China
- Zaswiza Mohamad Noor, Associate Professor, Academic
Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak - Malaysia
- Julie Ann Dopheide,Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences - United States of America

This digital event will describe how professional and regulatory organizations are supporting the pharmacy technician workforce throughout the world. Presenters will also discuss recent initiatives of the FIP Pharmacy Technicians Advisory Committee.

Learning Objectives:
● Identify ways that professional and regulatory bodies support the pharmacy technician workforce
● Recognize the role of advocacy in supporting the pharmacy technician workforce
● Describe recent projects of the Pharmacy Technicians Advisory Committee

Moderator:
- Catherine Schuster, Coordinator of Pharmacy Technician Programs Accreditation Canadian Council of Accreditation of Pharmacy Programs - Canada

Panellist:
- Dana Lyons, Technical Practice Manager Alberta Health Services - Canada
- Abigail Tan, Senior Pharmacy Technician KK Women's and Children's Hospital - Singapore
- Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board - United States

 How digital health is changing care delivery for pharmacists and improving public health

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

FIPWiSE (Women in Science and Education) is a programme that was launched by the International Pharmaceutical Federation (FIP) on 11 February 2020 on the United Nations’ International Day of Women and Girls in Science. Three years since its launch, several initiatives and transformation tools were introduced including FIPWiSE Toolkit for Positive Practice Environments for Women in Science and Education, FIPWiSE Rising Stars List, Women Leadership Lab, Fearless Podcast Series and Mentorship Programme

This special event is hosted so that, together, we can celebrate the 3^rd year anniversary of FIPWiSE. We will be revisiting the key outcomes delivered, reflecting on their successes, impacts and lessons, and discussing a future for FIPWiSE with the widest reach and social value. We want to reflect how FIPWiSE supports women to in pharmacy achieve their fullest potential, and to attract female students and young professionals into these fields. 

Learning objectives:

1. Celebrate the United Nations’ International Day of Women and Girls in Science.
2. Understand the aim and scope of the FIPWiSE programme and its key initiatives.
3. Discuss how the initiative can further support women in pharmaceutical science and education into the future.

Participants: 
- Catherine Duggan, FIP CEO, The Netherland
- Claire Thompson, FIPWiSE Chair, CEO Agility Life Sciences, UK
- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, FIP, The Netherlands
- Zuzana Kusynova, FIP Lead for Policy, Practice and Compliance, FIP, The Netherlands
- Aysu Selcuk, FIP Educational and Primary Health Care Policies Specialist, FIP - The Netherlands
- Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, FIP, The Netherlands
- Alison Etukakpan, FIP Educational Partnership Specialist, FIPt, The Netherlands
- Lilian Azzopardi, Head, Department of Pharmacy University of Malta, Malta
- Charlotte Rossing, Director of Research and Development, The Danish College of Pharmacy Practice, Denmark
- Marilyn Morris, Distinguished Professor and Chair of the Department of Pharmaceutical Sciences University at Buffalo, US
- Dalal Hammoudi Halat, Common Year Coordinator - QU Health, Qatar University, Qatar

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework permits, a broad range of point-of-care (POC) tests can be performed at community pharmacies or clinical biology laboratories. POC tests can provide valuable information to support health-related decision making and reduce unnecessary presentations to general practitioners or emergency departments. POC tests may also be provided as part of a disease state management service to monitor the outcomes of treatment in people with chronic non-communicable diseases. In addition, pharmacy professionals can use POC tests to intervene and provide safe and quick pharmaceutical care in acute situations.

Attendees will learn about:

1. The role of pharmacy professionals in point-of-care testing;
2. The importance of providing point-of-care testing services in the screening and management of chronic non-communicable diseases and acute situations;
3. Challenges and opportunities for pharmacists in addressing point-of-care testing services.

Moderator:
- Daragh Connolly, Chair of the FIP Board of Pharmaceutical Practice, Ireland

Panellists:
- Sherif Guorgui, President, FIP Community Pharmacy Section, Canada
- Julien Fonsart, Head of the Clinical Biology laboratory, Saint-Louis Lariboisiere University Hospitals, Greater Paris University Hospitals (APHP), France
- Teresa Torres. General Director of GO FAR ANF, Portugal
- Efi Mantzourani, Reader in Pharmacy Practice / Research and Evaluation Lead in Choose Pharmacy, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University / Primary Care, Digital Health and Care Wales, NHS Wales, UK

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

With increased economic, professional practice and workplace pressures, there is increasing evidence that pharmacists’ wellbeing is being negatively affected. Therefore, this needs to be addressed and it is critical for all pharmacy workplaces to be supported with evidence-based strategies and approaches that can be adapted for country context to foster a culture conducive to positive mental health and wellbeing.

The FIP Community Pharmacy Section is undertaking global research and will be creating policy documents for national organisations to base their own country strategies to address this critical problem and contribute to the sustainability of the profession.

We invite everyone to participate in an upcoming FIP Community Pharmacy Section interactive, engaging, and participative online workshops that will inform the production of a report to be presented at the Brisbane Congress.

Your region will be one of six around the world to contribute to this critical work in assisting FIP in developing a strategic position. Participation would involve sharing your perspectives, learning from peers in other countries and contributing to global research in community pharmacy practice.

The overall aim of this body of work conducted by the FIP Community Pharmacy Section is to analyse individual pharmacists’ experiences at a global level to enable the development of policies and strategies

More specifically, the objectives of these regional online workshops are to:

- Ascertain the workplace pressures that individual pharmacists or employers are facing,
- Determine how these workplace pressures are impacting their wellbeing and their practice,
- Determine what individual pharmacists or employers are doing to address this (strategies).

This webinar will focus on how to develop innovative pharmacy education curricula to better respond to global public health needs. It will also discuss the importance of covering all pharmacy fields and specialties in the pharmacy program, and how to integrate digital health in the global pharmacy education to continuously enhance the quality of education and competencies of the pharmaceutical workforce, as having competent pharmaceutical workforce is critical to providing quality health care services

1. Highlight the importance of quality of education for pharmaceutical workforce to provide high quality health services
2. Understand the innovative pharmacy education curricula
3. Providing effective strategies for comprehensive pharmacy education and training
4. Examining global tools and approaches to integrate e-learning and digital health to enhance the quality of pharmacy education and competencies of health

Moderators:
- Hanane Kebaili, President of the Algerian Early Career Pharmacists Group , Fédération Algérienne de Pharmacie, Algeria
- Abby A. kahaleh, PhD, MS, BPharm, MPH, FAACP, Board of Trustees Faculty & Tenured Faculty of Clinical and Administrative Sciences, RUCSHP, USA

Panellists:
- Abeer Al-Ghananeem, Professor of Pharmaceutics and Biopharmaceutics, Associate Dean for Research College of Pharmacy and Health Sciences, Sullivan University, Louisville, Kentucky, USA
- Anisha Sandhu, FIP AcPS Communication & Collaboration Working Group Member, FIP Technology Forum Committee Member; Assistant Lecturer, Monash University Malaysia School of Pharmacy, Malaysia
- Martin Henman, Associate Professor in the Practice of Pharmacy, The School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland
- Carl Schneider, Associate Professor in Pharmacy Practice, The University of Sydney School of Pharmacy, Faculty of Medicine and Health, Australia

The COVID-19 pandemic highlighted the requirement for current and future pharmacy education to be improved to strengthen the pharmacy profession and improve resilience. With the demand and options at higher education increasing, enrolment strategies have become more critical to pharmacy institutions.

FIP AIM has developed a handbook to support academic pharmacy leaders to update enrolment management strategies in schools of pharmacy. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help global health leaders to implement new enrolment methods.

• Develop strategies to recruit more and better students into pharmacy schools using traditional and social media
• Advocate for the profession, its scope of practice, and its importance in the healthcare system
• Reflect on a global integrated approach to foster student interest and improve admissions

Moderator:
- Pierre Moreau, Dean FIP, Kuwait University, Kuwait

Facilitator:
- Ozge Ozer, FIP Educational Partnership Manager, Turkey

Panellists:
- Lilian Azzopardi, FIP AIM Chair-elect & AIM Advisory Committee member, Head, Department of Pharmacy University of Malta-Malta
- Brian Hemstreet, Associate Dean for Student Affairs University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences-USA
- Frank Moriarty, Pharmacist and senior research fellow RCSI School of Pharmacy and Biomolecular Sciences-Ireland
- Gea Abigail U. Ecoy, Assistant Professor and Chair University of San Carlos-Philippines
- Hanan Refaat, Dean Future University-Egypt
- Marlon Prince, FIP AIM member, Director of Admissions at Howard University College of Pharmacy-USA
- Mohd Zulkefeli Mat Jusoh, FIP AIM member, Dean International Medical University-Malaysia
- Rajani Shakya, Head of Department of Pharmacy Kathmandu University-Nepal
- Wendy Cox,Assoc. Dean, Admissions and Accreditation, University of North Carolina at Chapel Hill Eshelman School of Pharmacy-USA

Telepharmacy has gained increasing importance in the delivery of pharmaceutical care, largely due to the COVID-19 pandemic which has placed enormous pressures on healthcare systems globally. There are some innovative models of telepharmacy services aimed at optimizing and improving access to pharmaceutical care, resulting in improved patient safety and outcomes. However, despite these benefits, major barriers for implementation of telepharmacy remain such as patient confidentiality and privacy of health information.

Attendees will learn about:

1. The global role of telehealth in supporting primary health care services
2. The current trends in telepharmacy around the globe
3. Examples of good practice in telepharmacy

Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden

Panellists:
- Rúben Viegas, Practice Development and Transformation Projects Coordinator, The Netherlands
- Sarah Dineen-Griffin, FIP CPS ExCo member, Australia
- Jaime Acosta, Community pharmacist Farmacia Acosta, Spain
- Josep M. Guiu-Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain
- Derrick Muneene, Unit Head, Digital Health Capacity Building and Collaboration, WHO, Switzerland 

Biorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behavior. An in vitro performance test which mimics the intraluminal performance of an oral dosage form is termed biorelevant. Biorelevant tests have been utilized to decrease the number of in vivo studies required during the drug development process and to mitigate the risk related to in vivo bioequivalence studies.

Prediction of intraluminal performance of an orally administered dosage form and the active pharmaceutical ingredient with biorelevant in vitro performance testing requires appropriate simulation of luminal conditions. Key luminal parameters to be simulated may vary with the process to be simulated, the structure of the active pharmaceutical ingredient and the type of dosage form. A variety of biorelevant media have been proposed, making it now possible to simulate most regions in the gastrointestinal tract in both prandial states. The levels of biorelevance and accompanying decision tree may serve as a useful tool during formulation development, in order to ensure high quality, predictive performance results without unnecessary complexity of media.

• Participants will be introduced in biorelevant dissolution testing
• Participants will be informed on dissolution media that simulates the physicochemical characteristics of the contents of the gastrointestinal lumen
• Participants will be informed on the in vitro methodologies that have been shown to be useful in simulating the intraluminal environment

Chair:
- Horst-Dieter Friedel, FIP Chair Regulatory Sciences and Quality, Director Former at Bayer AG, Germany

Moderator:
- Christos Reppas, Professor in Pharmaceutics National and Kapodistrian University of Athens, Greece

Guests:
- Maria Vertzoni, Associate Professor in Pharmaceutical Technology and Biopharmaceutics National and Kapodistrian University of Athens, Greece

One year after the launch of the FIP global call to action on advancing pharmaceutical education, FIP will report on each region’s progress against the call to action, building on the results of the FIP-UNITWIN inter-regional impact workshops held in November 2022. The event will also host the launch of the FIP Education transformation toolkit, which will be a collection of FIP’s relevant publications and digital events to implement the FIP global call to action on advancing pharmaceutical education.

Objectives:
1. Present progress since 2021 on priority FIP Development Goals of the regions in the context of pharmaceutical education
2. Present progress on FIP-UNITWIN regional roadmaps 2021 and the impact on FIP global call to action on pharmaceutical education
3. Discuss the way forward for the delivery of each regions’ roadmaps with establishment of regional FIP-UNITWIN centres for excellence programme in the months ahead
4. Launch the FIP Education transformation toolkit

Moderators:
- Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences- USA
- Lilian Azzopardi, FIP AIM Chair-elect , University of Malta -Malta

Guests:
- Dominique Jordan, FIP President, Switzerland
- Catherine Duggan, FIP CEO, UK

Panellists:
- Toyin Tofade, President Albany College of Pharmacy and Health Sciences, USA
- Silvana Nair Leite, Professor Federal University of Santa Catarina, Brazil
- Arinola Joda, Assistant Secretary & Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
- Rajani Shakya, Ass.Prof. Department of Pharmacy, Kathmandu University, Nepal
- Mohamad Rahal, Dean School of Pharmacy, Lebanese International University, Lebanon
- Paul Gallagher, Prof.Department of Pharmacy, National University of Singapore, Singapure
- Nilhan Uzman, FIP Lead for Education & Primary Health Policies, Turkey
- Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria

Pharmacists as athlete support personnel have rooted themselves as key players in medical teams serving athletes. Sports pharmacy evolved from a niche practice during the establishment of WADA two decades ago, gaining traction with the publication of the FIP guidelines “The Role of the Pharmacist in the Fight against Doping in Sport” in 2014. Today, we recognise sports pharmacy as a specialty practice, fundamental to the antidoping movement and athlete health. Pharmacists provide accurate sports drug information, avoid inadvertent doping, and coordinate pharmacy services at sporting events. We present two successful models in education and proper training of pharmacists to work with athletes.

Attendees will learn about:

1. Exploring the specialty of sports pharmacy based on expert consensus
2. Discussing a foundation for sports pharmacy curricula
3. Describing a successful example of sports pharmacy practice

Moderator:
- Daragh Connolly, Chair Board of Pharmaceutical Practice, Ireland

Panellists:
- Ashley Anderson, Clinical Sports Pharmacy Specialist / Antidoping Pharmacist International Sports Pharmacists Network, USA
- David Mottram, Emeritus Professor- Liverpool John Moores University, UK
- Mark Stuart, Pharmacist to the International Olympic Committee Medical Commission International Olympic Committee, UK
- Claire May, Academic University of Brighton, UK
- Somer Helvaci, Lecturer IOC accredited sports pharmacist, Turkey
- Shigeo Yamamura, Specially-Appointed Professor Josai International University, Japan

The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.

By the end of the session participants should be able to:
• Understand the roles pharmacists can play in HIV prevention, screening and management
• Recognise some resources and tools that pharmacists can use in this area
• Find and use the FIP toolkit on HIV prevention, screening and management

Moderator:
- Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa

Panellists:
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
- Ali Ahmed, Ph.D. Final Year Student (Clinical Pharmacy) Monash University Malaysia, Malaysia
- Alicia Krüger, Clinical pharmacist Brazilian federal council of pharmacy, Brazil
- Elise HARO-BRUNET, Employed pharmacist CESPHARM (prevention committee) / French Chamber of pharmacists, France
- Romeo Ongpoy Jr, Dean Emilio Aguinaldo College - Cavite Campus, Philippines
- Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, USA
- Hamish Bowden, Senior Clinical Pharmacist (HIV & Sexual Health) The Albion Centre NSW Health, Australia

Long covid, also known as post COVID-19 condition, is estimated to affect 10-20% of people who develop COVID-19. While the majority go on to fully recover, this group of people suffer a variety of physical, physiological and cognitive symptoms for many weeks, months and sometimes longer. The condition can be debilitating and recovery requires a holistic and personalised care approach, including pharmaceutical care.

This event by FIP aims to explore in more depth what long covid is, what the key characteristics and symptoms are and how these symptoms can be managed in the pharmacy. The panellists include a public health expert on long-covid-19, a clinical pharmacist who is recovering from long covid, a physiotherapist and more.

Learning objectives:
1. Describe the key characteristics and symptoms of long COVID-19
2. Understand the latest research and evidence concerning treatment and care
3. Discuss ways long covid symptoms can be managed in the pharmacy
4. Identify the importance of pharmacists' understanding of the condition and care needs

Moderator:
- Leonila Ocampo, FIP Community Pharmacy Section, Asia Pacific Institute for Medication Management Philippine Pharmacists Association, Philippines

Panellists:
- Darren Brown, Clinical Academic Physiotherapist, Chelsea and Westminster Hospital NHS Foundation Trust; Long COVID Physio, United Kingdom
- Rani Khatib, Consultant Cardiology Pharmacist and Associate Professor University of Leeds, United Kingdom
- Lucette Cysique, Associate Professor The University of New South Wales, Australia

Competent pharmaceutical workforce is vital to ensure healthy lives and promote well-being. This is aligned with the FIP Development Goals. Competency-base education (CBE) model became a core of healthcare professions education and training globally.

Some challenges are encountered relating to the implementation of CBE model to initial pharmacy and pharmaceutical education and training (IPET). Hence, FIPEd team has developed the handbook to support pharmacy leaders and educators for their journey of CBE implementation in their education programme. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help them implement CBE.


Learning objectives:
• Understand the importance of CBE in pharmacy and pharmaceutical education
• Describe the structure of FIPEd CBE Implementation Handbook
• Identify how the Handbook can support oneself for their CBE implementation journey

Moderators:
- Marwan Akel, Projects Manager – FIP Workforce development, evidence & impact Journal Editor – Pharmacy Education Journal (PEJ), Lebanon
- Dalia Bajis, FIP Lead for Provision & Partnerships, Bahrain

Panellists:
- Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK
- Jessica McMullen, Pharmacist and PhD Student University of Nottingham, UK
- Andries Koster, Associate Professor of Pharmacology Dept. Pharmaceutical Sciences, Utrecht University, The Netherlands
- Pierre Moreau, Professor of pharmacology and therapeutics College of pharmacy Kuwait University, Kuwait
- Shaun Gleason, Global Lead for Academic Capacity, FIP Workforce Development Hub, Assistant Dean for Distance Degrees and Programs; Associate Professor of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy, USA

With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to:
• Provide education and development
• Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans.
• Inform the 2023 Commitment to Action and Health Ministers Summit.

Learning objectives:
With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:

1. Outline regional educational and development headline needs in AMR and AMS,
2. Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
3. Input on how they can contribute to the FIP AMR 2023 plans.

Chair:
- Manjiri Gharat, FIP Vice President & Chair of the FIP Commission on AMR, India

Guest:
- Victoria Rutter, Executive Director, CPA, UK

Facilitators:
- Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain
- Chin-Yen Yeo, Senior AMS Pharmacist, Concord Repatriation General Hospital, Australia
- Fiona Doukas, Senior Project Officer, ACSQHC, Australia

Panellists:
- Usman Ebubakar, Senior Lecturer, Universiti Sains Malaysia, Malaysia
- Michelle Gijzelaar, National Clinical Pharmacy Manager, Life Healthcare, South Africa
- Onyeka Chinwuba Obidiegwu, Lecturer, Nnamdi Azikiwe University, Awka, Nigeria
- Roop Gupta, Vice President, IPA, India
- Syamhanin Adnan, Leader, AMS Focus Group for Pharmacist, MPS, Malaysia
- Fitria Nur Hidayah, Clinical Pharmacist, Cipto Mangunkusumo Hospital, Indonesia

With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to:
• Provide education and development
• Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans.
• Inform the 2023 Commitment to Action and Health Ministers Summit.

Learning objectives:
With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:

1. Outline regional educational and development headline needs in AMR and AMS,
2. Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
3. Input on how they can contribute to the FIP AMR 2023 plans.

The US public benefits from reduced costs and improved access to treatment enabled by availability of generics drug products. Patients offer a unique perspective when advocating for accessibility to high-quality and affordable generics. As critical stakeholders, it is important that the FDA Office of Generic Drugs (OGD) captures patient perspectives, needs, and priorities to help better inform patients. This session will explore the role of patients in generic drug development, OGD’s patient engagement sessions to date and the opportunities that can be used to improve patient engagement.

Learning objectives:

• The FDA’s perspectives on patient’s role in drug development
• How Office of Generic Drugs (OGD) is working on patient engagement

Moderator:
- Mathew Cherian, FIP IPS ExCo Member for Webinars, Consultant, USA

Co-moderator :
- Maria Mantziri, FIP IPS ExCo Associate, Pharmacist, Pharmacovigilance Scientist, Greece

Panellist:
- Sarah Ibrahim, Associate Director CDER, Office of Generic Drugs, FDA, USA

As we approach a post-pandemic world, the global supply chain has been greatly influenced by various factors. Many different drug and product shortages have been exacerbated in recent years due to supply chain issues. Through this webinar, we want to give a better overview of understanding the current global supply chain, current threats to the supply chain such as drug shortages, natural disasters, counterfeit medicines, and how to create a resilient supply chain as we move forward in society. We also want to emphasize the value of a pharmacist in this area and the difference they can make.

Learning Objectives:
1. Describe the current global pharmacy supply chain
2. Compare the contrast the different threats to the pharmacy supply chain such as drug shortages, natural disasters, and counterfeit medicines
3. Understand how these threats can interrupt the supply chain from each panel member’s perspective/countries
4. Outline how to create a resilient supply chain and future endeavours taking place to protect the supply chain (i.e., automation and technology)

Moderator:
- Rob Moss, PharmD, Immediate past president, FIP Hospital Pharmacy Section, FIP, European Association of Hospital Pharmacists, The Netherlands

Panellists:
- Yuh Lih Chang, PhD, RPh Director, Department of Pharmacy, Taipei Veterans General Hospital; Principal Investigator, National Drug Shortage management Project; Associate Professor, National Yang-Ming Chiao-Tung University, Taiwan Veterans General Hospital, National Yang-Ming Chiao-Tung University, Taiwan
- Dr. Sohail Fitieh, Ph.D, MS PLA, RPh, Pharmacy & Supply Chain Consultant, United Arab of Emirates
- Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Senior Director, Pharmacy Practice and Quality, American Society for Health-System Pharmacists, USA

The FIP Development Goal 3 (Quality Assurance) Leads have developed a pharmacy education quality assurance tool. It can be used as a self-assessment tool, and for data collection to better understand quality assurance of pharmacy education programmes in different countries around the world.

The questions relate to the pharmacy degrees for initial entry to practice and/or licensure of pharmacists, reflected in three core sections:
1. Accreditation processes and accrediting bodies
2. Standards for quality assurance
3. Views on the value, relevance and outcomes of accreditation in the country

Learning Objectives:
1. To provide the rationale for conducting the FIP Quality Assurance in Pharmacy Education survey
2. To describe the three core sections in the QA tool
3. To provide information on completing the survey and potential benefits

Moderator:
- Abby A. Kahaleh, PhD, MS, BPharm, MPH, FAACP Tenured Faculty & Board of Trustees Faculty Roosevelt University College of Science, Health, & Pharmacy, USA

Panellists:
- Abeer M. AlGhananeem, DG3 Global Lead at FIP Workforce Development Hub, Associate Dean and Professor Sullivan University College of Pharmacy and Health Sciences, USA
- Banan Mukhalalati, Global lead for FIP Development Goal 3: quality assurance Assistant Professor Qatar University, Qatar

The FIP Global Competency Framework for Educators & Trainers in Pharmacy (FIP-GCFE) is a new tool to support advancement and competence development for our colleagues around the world, serving in any sector of pharmaceutical education. It was initiated by the Academic Pharmacy Section of FIP and created in collaboration across FIP, involving our leads, experts, volunteers across the Federation. This works is authored by experienced authors, global leaders in pharmaceutical education who are active in academic, practice and science fields of the pharmacy profession. The commitment to gather their knowledge, experience, values, and efforts, inspiring our colleagues to advance in the field of education, resulted in comprehensive and evidence-based framework.

Participants will be able to:
• Understand how to empower our individual and institutional members, focused on those involved in creating, delivering and assuring quality of pharmaceutical education.
• Learn about the valuable source of information and guide for educators and trainers in pharmacy at individual, organizational, national, and global levels.
• Understand how to use the Framework for their own personal and professional development.
• Start the application, research, and validation of the Framework
• Conduct the self-assessment of competencies according to the Framework

Moderators:
- Astrid Czock, FIP WDH Global Lead; CEO QualiCCare, Switzerland
- Marwan Akel, Projects Manager–Workforce development, evidence & impact Journal Editor – PEJ, Lebanon

Panellists:
- Arijana Mestrovic, FIP AcPS Vice President, FIP WDH Global lead for Competency Development; Director, Professional services
Pharma Expert, Croatia
- Mike Rouse, Director, International Services Accreditation Council for Pharmacy Education. USA
- Martin Charles Henman, FIP AcPS ExCO member Adjunct Assoc. Prof. Trinity College Dublin, Ireland
- Ian Bates, Chair of pharmacy education-University College London, UK
- Catherine Duggan, FIP CEO, Netherlands

GALF will be organised virtually in a workshop format to increase communication and collaboration between FIP AIM members. The GALF 2022 topic will be "Culture of innovation in academia".

Innovation can happen as a single event, but it can also become part of an organisation’s culture so that it is systematically engaged in significant and meaningful activities that will allow it to stand above the rest. Especially after the COVID-19 pandemic, the academia had to revisit the learning and teaching methods, and this workshop aims at exploring how a culture of innovation can be developed and sustained in academia, where traditions are engrained and change is not always an easy endeavour.

At the end of this session, participants will be able to:

• Understand the concepts of innovation and culture, and how they interact (For before and after the COVID-19 pandemic),
• Analyse their organisation and determine what domains would require innovation,
• Develop a strategy to gradually influence the behaviours to allow innovation to become part of the culture,
• In the light of the COVID-19 experience, plan change management activities that will allow the expected cultural evolution towards innovation, and
• Discuss examples of academic organisations that have relied on a culture of innovation to move forward.

This special event is held during a week which marks two significant dates for global health. We will have passed the 1000 days since 30 January 2020 when the World Health Organization declared the COVID-19 outbreak at the time as a Public Health Emergency. The same week will also mark the 4th anniversary since the world, including FIP, came together in Astana in 2018 to endorse the new Declaration of Astana emphasizing the critical role of primary health care. Join us on this special launch event on pandemic preparedness to learn about global pharmacy’s response to COVID-19 and discuss the important of resilient pharmacy and health systems.

Learning objectives:
1. Understand how FIP supported (and continues to support) its members during the pandemic
2. Describe how pharmacy leadership bodies responded to the pandemic across the world
3. Discuss country best practices and lessons for future pandemic preparedness
4. Learn about FIP’s map of primary health care, focusing on strengthening health systems and recovery

Moderator:

- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, Saudi Arabia

Panellists:
- Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA), South Africa
- Hala Sacre, CEO, INSPECT-LB, Lebanon
- Clare Fitzel, Head of Professional Services, Irish Pharmacy Union, Ireland
- Teresa Almeida, Member of the board of directors, Associação Nacional das Farmácias, Portugal
- Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta
- Leonor Soares, Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal
- Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan
- Atsushi Toyomi, Executive Director, Japan Pharmaceutical Association, Japan
- Sofía Segura, Professor, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica
- Roop Gupta, Chairman, Hospital Pharmacy Division and Vice President, India
- Jack Shen Lim, Treasurer, Malaysian Pharmacists Association, Malaysia
- Daragh Connolly, FIP Chair of BPP,  Ireland

FIP staff:
- Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands
- Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, Saudi Arabia 
- Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan
- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia 
- Nilhan Uzman, FIP lead for education and primary health care policies, The Netherlands

Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.

By the end of the session participants should be able to:
• Understand the importance of flu vaccination, especially for vulnerable population groups, like the elderly
• Recognize the need for improving vaccination coverage rates for both the flu and COVID-19.
• Discuss pharmacists’ contribution to flu vaccination strategies.

Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden

Panelists:
- Joshua A. Mott, Technical Advisor for Influenza and Pandemic Preparedness, WHO, Department of Epidemic and Pandemic Preparedness and Prevention, Switzerland
- Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
- Maria Mendes, Area Manager at the Centre for Medicines Information and Health Interventions (CEDIME) at the National Association of Pharmacies, Portugal National Association of Pharmacies, Portugal

The COVID19 pandemic has highlighted that we need better antiviral therapies, especially for respiratory viral diseases. We have developed inhalation therapies consisting of siRNA nanoparticles which inhibit the viral genome of coronaviruses. The advantage over vaccination is the therapeutic index for virus variants and new coronaviruses. Other so far undruggable targets are transcription factors which are often drivers of tumorigenesis. Accordingly, examples for pulmonary delivery of therapeutic RNA in asthma, targeting GATA-3, and in lung cancer, targeting mutated KRAS, will be discussed.

Learning objectives:
*siRNA nanoparticles for inhalation delivery
*Application to un- druggable targets like transcription factors

Moderator:
Mathew Cherian, ExCo Member, Industrial Pharmacy Section, Consultant-USA

Co-moderator:
Kaushik Desai, Associate ExCo Member, Industrial Pharmacy Section, Secretary General International Pharmaceutical Excipients’ Council of India-India

Panelist:
Olivia Merkel, Professor of Drug Delivery Ludwig Maxmillian University (LMU) Munich, Germany

Inequity has been identified as one of the most serious issues in education worldwide, with multiple causes and consequences. Recent evidence and findings from FIP research indicate that inequities in pharmaceutical education need to be addressed, and this FIP toolkit for addressing inequities in pharmaceutical education intends to motivate, assess, and inform forward thinking changes targeted at transforming pharmaceutical education through addressing inequities globally, across all regions and locally.

At the end of this session, participants will:
1. Learn about the vital inequity themes that impact pharmaceutical education;
2. Understand the importance of having equitable pharmaceutical education;
3. Discuss with the toolkit authors and high-level speakers how to take action towards enabling equitable pharmaceutical education nationally, regionally and globally

Moderator:
- Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA

Guests:
-Catherine Duggan, FIP CEO, The Netherlands

Panelists:
- Nilhan Uzman, FIP Lead for education and primary health care policies, The Netherlands
- Alison Ubong Etukakpan, FIP Educational Partnership Specialist, Nigeria
- Karima Bennara, Chairperson of pharmacy education, International Pharmaceutical Students Federation, Algeria
- Khalid Garba Mohammed, Post doctoral Fellow, Pharmaceutical Engineering Group, School of Pharmacy, Queens University Belfast, UK
- Oliver Grundmann, Clinical Professor The College of Pharmacy, University of Florida, USA
- Neelaveni Padayachee, Senior lecturer and Researcher Department of Pharmacy and Pharmacology, Pharmacy Practice Division, The University of Witwatersrand, South Africa
- Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, Turkey
- Dalal Hammoudi, Associate Dean for Assessment Lebanese International University, School of Pharmacy, Lebanon

Influenza and COVID-19 can have an important impact in health, productivity and quality of life, especially for vulnerable populations. Likewise, both diseases have vaccines that are available and support a lower risk of transmission of the disease.

Pharmacists can play a major role in reminding people to get vaccinated, building vaccine confidence and supporting their decision making, dispensing vaccines and, in some countries, administering those vaccines.  The coadministration of these vaccines can lead to an efficient and convenient way of improving vaccine uptake against both diseases. Community pharmacies’s accessibility and credibility put them in an ideal situation to provide this important service, thus making a valuable contribution to disease prevention.

This digital event will discuss the importance of promoting the coadministration of COVID-19 and flu vaccines as well as strategies for pharmacies’ involvement.

By the end of the session participants should be able to:

• Understand the benefits of vaccine coadministration
• Recognize the need for vaccination coverage in both flu and COVID-19
• Present the FIP Guideline on this topic

Moderator:

- Daragh Connolly, President, Community Pharmacy Section, Ireland

Panellist:

- Mitchel Rothholz, Immunization Consultant, Three-C Consulting, USA
- Lisa Nissen, Professor (Program Director) – Health Workforce Optimisation, Centre for Business and Economics of Health, (Faculty of Business), Australia
- Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal
- Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal

This will be a 2-part workshop to introduce the FIP YPG Career Development toolkit. Part 1 will review the toolkit, the available resources, and discuss how it will benefit the user. Attendees will then be instructed to work through the toolkit over the next few weeks.

Part 2 of the workshop will be an engaging session where participants are asked to return with their completed toolkits to discuss what they learned with other attendees, review their toolkits in breakout rooms, and have the opportunity to ask questions.

Consumers throughout the world are increasingly looking to the internet to purchase their drugs. The worldwide pandemic has caused many consumers, who had not done so previously, to look to the internet for healthcare, healthcare information and medicinal products. However, at any given time, 95% of the roughly 35,000 online drug sellers worldwide operate illegally, in violation of laws and placing consumers at risk. Drugs purchased through an illegal drug seller on the internet may contain no drug, subtherapeutic levels of a drug, a completely different drug, or toxic chemicals. These websites will appear to be “pharmacies” or other “medical centres” providing credible health care, drug information and safe and approved medications, but are not and present risk to the unknowing consumer.

Regulators throughout the world are monitoring the level of nefarious drug sellers and “medical clinics” on the internet. Regulatory solutions to combat and remove the presence of these harmful vendors and sites have not been widely implemented. Public awareness is an important step, but also raising the awareness among healthcare providers, law makers and social media platforms.

Learning Objectives:
-To identify the level of illegal online drug sellers and bogus medical clinics on the internet and impact on the unsuspecting public
-To identify the barriers to overcome and better protect the public.
To identify programs and initiatives currently in place to combat misinformation, poor virtual care and falsified medication to enhance the safety and protect the internet consumer
-To encourage and support standards for virtual care.

Moderator:
-Ronald Guse, Chair FIP Regulators Forum - Canada
Panelists:
-Mike Isles,Director Alliance for Safe Online Pharmacy-EU-UK
-Justin Macy,Digital Health Senior Manager National Association of Boards of Pharmacy-USA
-Libby Baney,Senior Advisor to ASOP Global; Partner, Faegre Drinker LLP, Alliance for Safe on Pharmacy Global-USA

The demand for travel health and travel medicine services is rapidly growing with the return levels of international travel. Patients are frequently turning to community pharmacies for advice on disease reduction and maintaining personal health whilst travelling. Pretravel preparation is important for many reasons one of which is supporting Global Health policies and strategies.

In some countries legislation has been devolved to allow pharmacists to prescribe medication and vaccinate travellers. However, this is not the situation globally and the many countries place restrictions on this type of pharmacy practice.

Learning objectives:
- To raise the awareness of pretravel consultation service that can be provided in a community setting without prescribing or vaccination.
- To identify over-the-counter products that can be supplied to support travellers visiting a pharmacy
- Compare and contrast classes of over-the-counter products for selected conditions and identify/select appropriate patients for their use.
- Showcase the collaborations with the International Institute of Travel Medicine through membership of ISTM and completion of Certificate of Health

Moderator:
- Daragh Connolly, President Community Pharmacy Section, Ireland

Panelists:
- Derek Evans, Pharmacist Specialist in Travel Medicine Evans Travel Health consultancy, UK
- Karl Hess, Director, Community Pharmacy Practice Innovations Department of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, California, USA
- Sheila Seed, Professor and Chair of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, USA
- Larry Goodyer, Professor of Pharmacy Practice, Leicester School of Pharmacy Faculty of Health and Life Sciences, De Montfort University, UK

The Universal Health Coverage (UHC) Competency Framework was published by WHO as a guide to progress towards building more holistic and integrated health systems. Critically, this includes human resources education and the implementation of Competency-Based Education (CBE) for healthcare workers to ensure adequate, and integrated, education and training.

WHO Universal Health Coverage Competency Framework: https://www.who.int/publications/i/item/9789240034686

Learning Objectives:

1. Overview of the principles and objectives of the WHO universal health coverage competency framework
2. Understand competency-based education and its role in developing the global healthcare workforce for UHC
3. Contextualize the UHC competency development guide to fulfil training needs - based on country of practice
4. Focus on pharmacy and pharmacy support workforce role in UHC

Moderator:
- Abigail Tan Ming Li, Staff training and the planning of continuing education topics. KK Women's and Children's Hospital, Singapore

Panelists:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, United Kingdom
- Siobhan Fitzpatrick, WHO technical officer WHO, Switzerland

This event is part of the cycle of joint webinars of the Association of Pharmacists of Portuguese-Speaking Countries (AFPLP) and the International Pharmaceutical Federation (FIP), called “Challenges and Opportunities for the Pharmaceutical Profession in the Lusophone Space”.

FIP has been promoting a program in the area of pharmaceutical training that includes the project to harmonize and strengthen pharmaceutical training in Sub-Saharan Africa, the establishment of an African association of pharmacy schools, and the development of a pharmaceutical workforce based on skills that respond to to the needs of each country.

Therefore, this event is organized to bring this initiative closer to the pharmaceutical science courses in Portuguese-speaking African countries.

The event will be moderated by the President of AFPLP, Mateus Fernandes, and the speaker representing FIP is Arinola E. Joda - Assistant Secretary General/Editor in Chief of the African Pharmaceutical Forum (APF), and Associate Professor at the Faculty of Pharmacy at the University of Lagos, Nigeria.

The sharing of national experiences will be in charge of Wison Aniba, Coordinator of the Pharmaceutical Sciences Course at the Piaget University of Angola, Dilson Pereira, Vice-Rector of the Piaget University of Cape Verde, and Saquina Rugunate, Coordinator of the Pharmacy Course at ISCTEM in Mozambique.

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.

Learning Objectives:
1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals
2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway

Moderators:
- Mathew Cherian, PhD Consultant, FIP Member, Executive Committee, Industrial Pharmacy Section, USA
- Maria Mantziri, Associate ExCo Member, IPS Webinars, Greece

Panelist:
- Jude Nwokike, Vice- President US Pharmacopeia, USA

The Pharmacy Education Journal (PEJ) continues to publish peer-reviewed manuscripts in the general scope of practise domain of pharmacy education (at all stages) and workforce development research and evaluation. PEJ is planning for widening scope by introducing educationally-related short, rapid response articles targeting non-traditional authors (non-academics) in Practice and Science sectors. PEJ is a key global dissemination route.

Event outcomes:

1 Showcase what did PEJ achieve during 20 years, how it was done and present the new plans.
2 Highlight the importance of publishing in the pharmaceutical workforce and education field.
3 Explain the steps from submission to publication: what happens behind the screen and who does it and provide some tips for authors.

Moderators:
- Marwan Akel, Projects Manager – Workforce development, evidence & impact Journal Editor – PEJ, FIP, Lebanon
- Sherly Meilianti, FIP Data and Intelligence Specialist, FIP, Indonesia

Panelists:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, UK
- Lilian M. Azzopardi, Prof. of Pharmacy Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta President, European Association of Faculties of Pharmacy, Malta
- Judilynn L. Niedo-Solidum, Prof. at University of the Philippines Manila College of Pharmacy, Philippines
- Rudi Hendra, Associate professor Indonesian Pharmacists Association, Indonesia
- Shane Desselle, RPh, PhD, FAPhA Professor of Social and Behavioral Pharmacy Touro University California College of Pharmacy, USA
- Jennifer Marriott, Adjunct Associate Professor, Australia

In order to ensure pharmacists maintain currency and quality in their practice, mandatory continuing professional development (CPD) programmes have been implemented by regulatory authorities as part of the licence renewal requirements for continuing practice. This webinar will provide information on the countries having a mandatory CPD programme, the various types of programmes, the regulations and the overall value and monitoring. In addition, information will be provided on CPD for specialized areas of practice, as part of returning to practice and some new concepts to insure currency and quality.

The attendees will learn:
-the overall importance of a mandated CPD programme from a quality assurance and patient safety perspective ;
-the variations of CPD programmes currently in place in various countries;
-the legislation/regulations in place mandating a CPD programme to maintain currency and enhance competence, quality assurance and patient safety;  
-recertification programs for "specialization" and "return to practice"; and,
-other innovative way to insure quality and currency of pharmacists.

Moderator:
- Brett Simmonds, Chair Pharmacy Board of Australia, Australia

Panelists:
- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, France
- Michael Pead, Chief Executive Pharmacy Council of New Zealand, New Zealand
- Trish Farrelly, Manager Registration and Competence Assurance, Pharmacy Council of New Zealand, New Zealand
- Joe R. Anderson, Assistant Dean for Curricular Affairs and Associate Professor of Pharmacy Practice and Administrative Sciences, The University of New Mexico College of Pharmacy, USA